| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 COL5A3 COL22A1 | 1.73e-39 | 46 | 63 | 20 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 COL5A3 COL22A1 EMILIN1 | 1.76e-27 | 188 | 63 | 21 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A1 COL4A2 COL4A3 MAGI2 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 MATR3 COL5A3 COL22A1 EMILIN1 PGM5 | 8.56e-17 | 891 | 63 | 24 | GO:0005198 |
| GeneOntologyMolecularFunction | integrin binding involved in cell-matrix adhesion | 9.74e-05 | 5 | 63 | 2 | GO:0098640 | |
| GeneOntologyMolecularFunction | integrin binding | 2.28e-04 | 175 | 63 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 3.48e-04 | 9 | 63 | 2 | GO:0098634 | |
| GeneOntologyMolecularFunction | heparin binding | 3.49e-04 | 192 | 63 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 6.34e-04 | 12 | 63 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.56e-03 | 268 | 63 | 5 | GO:0005539 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 TGFBR3 COL5A1 COL5A2 COL24A1 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL28A1 COL27A1 ADAMTS17 COL5A3 TFIP11 COL22A1 ITGB1 EMILIN1 PBXIP1 | 2.66e-25 | 377 | 58 | 23 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 TGFBR3 COL5A1 COL5A2 COL24A1 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL28A1 COL27A1 ADAMTS17 COL5A3 TFIP11 COL22A1 ITGB1 EMILIN1 PBXIP1 | 2.82e-25 | 378 | 58 | 23 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 TGFBR3 COL5A1 COL5A2 COL24A1 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL28A1 COL27A1 ADAMTS17 COL5A3 TFIP11 COL22A1 ITGB1 EMILIN1 PBXIP1 | 3.00e-25 | 379 | 58 | 23 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.15e-10 | 12 | 58 | 5 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 1.23e-09 | 18 | 58 | 5 | GO:0038065 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.80e-09 | 76 | 58 | 7 | GO:0030199 | |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 4.65e-05 | 4 | 58 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | COL4A1 COL4A2 COL4A3 TGFBR3 COL5A1 COL5A2 FLNC COL8A2 PAX8 COL27A1 MATR3 ITGB1 EMILIN1 PGM5 | 4.67e-05 | 1483 | 58 | 14 | GO:0048646 |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 1.16e-04 | 6 | 58 | 2 | GO:1903225 | |
| GeneOntologyBiologicalProcess | circulatory system development | COL4A1 COL4A2 COL4A3 TGFBR3 COL5A1 COL8A2 COL11A1 PAX8 COL27A1 MATR3 RIPPLY3 ITGB1 EMILIN1 | 1.47e-04 | 1442 | 58 | 13 | GO:0072359 |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in morphogenesis | 1.62e-04 | 7 | 58 | 2 | GO:1902338 | |
| GeneOntologyBiologicalProcess | tendon development | 1.62e-04 | 7 | 58 | 2 | GO:0035989 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in development | 2.15e-04 | 8 | 58 | 2 | GO:1904746 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | COL5A1 COL5A2 FLNC COL11A1 COL28A1 COL27A1 COL5A3 ITGB1 EMILIN1 PGM5 | 3.03e-04 | 957 | 58 | 10 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 3.45e-04 | 10 | 58 | 2 | GO:1903224 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 4.21e-04 | 11 | 58 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | embryo development | TGFBR3 COL5A1 COL5A2 COL11A1 PAX8 COL27A1 MATR3 UBTFL1 RIPPLY3 DLX4 ITGB1 PRRC2B | 5.54e-04 | 1437 | 58 | 12 | GO:0009790 |
| GeneOntologyCellularComponent | collagen trimer | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 MBL2 COL5A3 COL22A1 EMILIN1 MARCO | 5.21e-40 | 88 | 62 | 23 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL11A1 COL28A1 COL27A1 COL5A3 | 2.11e-23 | 21 | 62 | 11 | GO:0098644 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 ADAMTS17 COL5A3 TFIP11 COL22A1 ITGB1 EMILIN1 MARCO ALPL | 3.66e-23 | 656 | 62 | 26 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 ADAMTS17 COL5A3 TFIP11 COL22A1 ITGB1 EMILIN1 MARCO ALPL | 3.95e-23 | 658 | 62 | 26 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 ADAMTS17 COL5A3 COL22A1 ITGB1 EMILIN1 MARCO | 1.18e-22 | 530 | 62 | 24 | GO:0062023 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL22A1 | 9.05e-20 | 332 | 62 | 19 | GO:0005788 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 4.84e-13 | 12 | 62 | 6 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 4.84e-13 | 12 | 62 | 6 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.17e-12 | 6 | 62 | 5 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.08e-11 | 8 | 62 | 5 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.08e-11 | 8 | 62 | 5 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.08e-11 | 8 | 62 | 5 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen type V trimer | 7.01e-11 | 4 | 62 | 4 | GO:0005588 | |
| GeneOntologyCellularComponent | basement membrane | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL8A2 COL28A1 ITGB1 | 9.11e-11 | 122 | 62 | 9 | GO:0005604 |
| GeneOntologyCellularComponent | collagen type IX trimer | 9.92e-08 | 4 | 62 | 3 | GO:0005594 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 FLNC COL11A1 COL28A1 COL27A1 COL5A3 PBXIP1 MEFV PGM5 | 2.42e-07 | 1187 | 62 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | collagen type XI trimer | 2.47e-07 | 5 | 62 | 3 | GO:0005592 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 4.94e-07 | 6 | 62 | 3 | GO:0005593 | |
| GeneOntologyCellularComponent | integrin alpha4-beta1 complex | 2.59e-05 | 3 | 62 | 2 | GO:0034668 | |
| GeneOntologyCellularComponent | sarcolemma | 2.50e-04 | 190 | 62 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL5A1 COL5A2 COL6A3 FLNC COL11A1 COL28A1 COL27A1 COL5A3 PBXIP1 MEFV PGM5 | 6.27e-04 | 1179 | 62 | 11 | GO:0099512 |
| GeneOntologyCellularComponent | costamere | 1.92e-03 | 22 | 62 | 2 | GO:0043034 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.15e-03 | 785 | 62 | 8 | GO:0098797 | |
| GeneOntologyCellularComponent | integrin complex | 4.05e-03 | 32 | 62 | 2 | GO:0008305 | |
| HumanPheno | Osteoarthritis | 3.80e-08 | 65 | 28 | 7 | HP:0002758 | |
| HumanPheno | Limb pain | 1.19e-05 | 57 | 28 | 5 | HP:0009763 | |
| HumanPheno | Lenticonus | 1.74e-05 | 10 | 28 | 3 | HP:0001142 | |
| HumanPheno | Cigarette-paper scars | 1.74e-05 | 10 | 28 | 3 | HP:0001073 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 2.91e-05 | 2 | 28 | 2 | HP:0006524 | |
| HumanPheno | Dyspepsia | 2.91e-05 | 2 | 28 | 2 | HP:0410281 | |
| HumanPheno | Diffuse leiomyomatosis | 2.91e-05 | 2 | 28 | 2 | HP:0006756 | |
| HumanPheno | Glomerular basement membrane lamellation | 8.71e-05 | 3 | 28 | 2 | HP:0030034 | |
| HumanPheno | Fragmentation of the metacarpal epiphyses | 8.71e-05 | 3 | 28 | 2 | HP:0009189 | |
| HumanPheno | Fragmented epiphyses of the upper limbs | 8.71e-05 | 3 | 28 | 2 | HP:0003841 | |
| HumanPheno | Radially deviated wrists | 8.71e-05 | 3 | 28 | 2 | HP:0006190 | |
| HumanPheno | Anterior lenticonus | 8.71e-05 | 3 | 28 | 2 | HP:0011501 | |
| HumanPheno | Abnormality of the epiphyses of the elbow | 8.71e-05 | 3 | 28 | 2 | HP:0003946 | |
| HumanPheno | Vulvar neoplasm | 8.71e-05 | 3 | 28 | 2 | HP:0030416 | |
| HumanPheno | Subcutaneous spheroids | 8.71e-05 | 3 | 28 | 2 | HP:0025014 | |
| HumanPheno | Precordial pain | 8.71e-05 | 3 | 28 | 2 | HP:0032141 | |
| HumanPheno | Knee pain | 9.61e-05 | 17 | 28 | 3 | HP:0030839 | |
| HumanPheno | Abnormality of lens shape | 1.15e-04 | 18 | 28 | 3 | HP:0011526 | |
| HumanPheno | Dilatation of the cerebral artery | 1.53e-04 | 51 | 28 | 4 | HP:0004944 | |
| HumanPheno | Cervical insufficiency | 1.74e-04 | 4 | 28 | 2 | HP:0030009 | |
| HumanPheno | Piezogenic pedal papules | 1.74e-04 | 4 | 28 | 2 | HP:0025509 | |
| HumanPheno | Ulnar deviated club hands | 1.74e-04 | 4 | 28 | 2 | HP:0006055 | |
| HumanPheno | Reduced arm span | 1.74e-04 | 4 | 28 | 2 | HP:0012770 | |
| HumanPheno | Incisional hernia | 1.74e-04 | 4 | 28 | 2 | HP:0004872 | |
| HumanPheno | Vitreoretinopathy | 2.14e-04 | 22 | 28 | 3 | HP:0007773 | |
| HumanPheno | Pain | COL4A3 MAGI2 COL4A5 COL4A6 COL5A1 COL5A2 FLNC COL8A2 COL9A2 COL9A3 COL11A1 MATR3 MEFV | 2.16e-04 | 846 | 28 | 13 | HP:0012531 |
| HumanPheno | Small epiphyses | 2.79e-04 | 24 | 28 | 3 | HP:0010585 | |
| HumanPheno | Fragmented epiphyses | 2.88e-04 | 5 | 28 | 2 | HP:0100168 | |
| HumanPheno | Amblyopia | 3.08e-04 | 112 | 28 | 5 | HP:0000646 | |
| HumanPheno | Arthritis | 3.15e-04 | 251 | 28 | 7 | HP:0001369 | |
| HumanPheno | Irregular epiphyses | 3.16e-04 | 25 | 28 | 3 | HP:0010582 | |
| HumanPheno | Abnormality of radial epiphyses | 4.31e-04 | 6 | 28 | 2 | HP:0003999 | |
| HumanPheno | Myopia | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL9A2 COL9A3 COL11A1 ADAMTS17 | 4.32e-04 | 447 | 28 | 9 | HP:0000545 |
| HumanPheno | Facial edema | 5.93e-04 | 129 | 28 | 5 | HP:0000282 | |
| HumanPheno | Pulp calcification | 6.02e-04 | 7 | 28 | 2 | HP:0003771 | |
| HumanPheno | Phalangeal dislocation | 6.02e-04 | 7 | 28 | 2 | HP:0006243 | |
| HumanPheno | Abnormality of the epiphyses of the feet | 6.02e-04 | 7 | 28 | 2 | HP:0010631 | |
| HumanPheno | Molluscoid pseudotumors | 6.02e-04 | 7 | 28 | 2 | HP:0000993 | |
| HumanPheno | Uterine prolapse | 6.02e-04 | 7 | 28 | 2 | HP:0000139 | |
| HumanPheno | Waddling gait | 6.14e-04 | 130 | 28 | 5 | HP:0002515 | |
| HumanPheno | Stage 5 chronic kidney disease | 7.30e-04 | 135 | 28 | 5 | HP:0003774 | |
| HumanPheno | Abnormality of upper limb joint | COL5A1 COL5A2 COL6A3 FLNC COL9A2 COL9A3 COL11A1 COL27A1 MATR3 CDH3 EMILIN1 | 7.51e-04 | 705 | 28 | 11 | HP:0009810 |
| HumanPheno | Genital hernia | 7.99e-04 | 8 | 28 | 2 | HP:0100823 | |
| HumanPheno | Arterial rupture | 7.99e-04 | 8 | 28 | 2 | HP:0025019 | |
| HumanPheno | Anti-smooth muscle antibody positivity | 7.99e-04 | 8 | 28 | 2 | HP:0003262 | |
| HumanPheno | Blepharochalasis | 7.99e-04 | 8 | 28 | 2 | HP:0010749 | |
| HumanPheno | Abnormal cerebral vascular morphology | 8.42e-04 | 388 | 28 | 8 | HP:0100659 | |
| HumanPheno | Abnormal morphology of the radius | 9.55e-04 | 217 | 28 | 6 | HP:0002818 | |
| HumanPheno | Atrophic scars | 1.02e-03 | 37 | 28 | 3 | HP:0001075 | |
| HumanPheno | Arthralgia of the hip | 1.02e-03 | 9 | 28 | 2 | HP:0003365 | |
| HumanPheno | Increased circulating thyroglobulin concentration | 1.02e-03 | 9 | 28 | 2 | HP:0025484 | |
| HumanPheno | Abnormal knee physiology | 1.19e-03 | 87 | 28 | 4 | HP:0034670 | |
| HumanPheno | Schizencephaly | 1.28e-03 | 10 | 28 | 2 | HP:0010636 | |
| HumanPheno | Vaginal neoplasm | 1.28e-03 | 10 | 28 | 2 | HP:0100650 | |
| HumanPheno | Lower limb pain | 1.38e-03 | 41 | 28 | 3 | HP:0012514 | |
| HumanPheno | Abnormal forearm bone morphology | 1.48e-03 | 236 | 28 | 6 | HP:0040072 | |
| HumanPheno | Abnormal arm span | 1.55e-03 | 11 | 28 | 2 | HP:0012769 | |
| HumanPheno | Abnormal forearm morphology | 1.58e-03 | 239 | 28 | 6 | HP:0002973 | |
| HumanPheno | Lens dislocation | 1.58e-03 | 43 | 28 | 3 | HP:0000665 | |
| HumanPheno | Ectopia lentis | 1.58e-03 | 43 | 28 | 3 | HP:0001083 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 1.59e-03 | 94 | 28 | 4 | HP:0006500 | |
| HumanPheno | High myopia | 1.59e-03 | 94 | 28 | 4 | HP:0011003 | |
| MousePheno | abnormal blood vessel morphology | COL4A1 COL4A2 COL4A3 MAGI2 COL4A5 TGFBR3 COL5A1 COL5A2 FLNC PAX8 COL28A1 COL27A1 MATR3 RIPPLY3 ITGB1 EMILIN1 PRRC2B | 2.75e-06 | 1472 | 47 | 17 | MP:0001614 |
| MousePheno | podocyte foot process effacement | 7.61e-06 | 38 | 47 | 4 | MP:0008140 | |
| MousePheno | abnormal thyroid gland morphology | 1.04e-05 | 87 | 47 | 5 | MP:0000681 | |
| MousePheno | abnormal forelimb stylopod morphology | 1.36e-05 | 92 | 47 | 5 | MP:0003854 | |
| MousePheno | abnormal humerus morphology | 1.36e-05 | 92 | 47 | 5 | MP:0005296 | |
| MousePheno | abnormal glomerular capillary morphology | 1.80e-05 | 47 | 47 | 4 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 1.96e-05 | 48 | 47 | 4 | MP:0011310 | |
| MousePheno | hematuria | 3.32e-05 | 19 | 47 | 3 | MP:0005161 | |
| MousePheno | abnormal podocyte foot process morphology | 3.37e-05 | 55 | 47 | 4 | MP:0008059 | |
| MousePheno | lens vacuoles | 3.90e-05 | 20 | 47 | 3 | MP:0011697 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | COL4A1 COL4A2 MAGI2 TGFBR3 FLNC CACNB1 COL11A1 PAX8 COL27A1 MATR3 RIPPLY3 ITGB1 MEFV ALPL | 4.67e-05 | 1269 | 47 | 14 | MP:0011111 |
| MousePheno | albuminuria | 5.78e-05 | 63 | 47 | 4 | MP:0002871 | |
| MousePheno | buphthalmos | 6.61e-05 | 4 | 47 | 2 | MP:0009274 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 8.74e-05 | 70 | 47 | 4 | MP:0011497 | |
| MousePheno | abnormal podocyte morphology | 8.74e-05 | 70 | 47 | 4 | MP:0005326 | |
| MousePheno | abnormal aorta morphology | 1.01e-04 | 225 | 47 | 6 | MP:0000272 | |
| MousePheno | abnormal kidney vasculature morphology | 1.03e-04 | 73 | 47 | 4 | MP:0000530 | |
| MousePheno | abnormal skeleton development | 1.08e-04 | 447 | 47 | 8 | MP:0002113 | |
| MousePheno | anterior polar cataract | 1.10e-04 | 5 | 47 | 2 | MP:0010259 | |
| MousePheno | abnormal limb morphology | COL4A2 TGFBR3 FLNC CACNB1 COL9A2 COL11A1 PAX8 COL27A1 ADAMTS17 DUOX2 ITGB1 PBXIP1 | 1.10e-04 | 1028 | 47 | 12 | MP:0002109 |
| MousePheno | renal tubule atrophy | 1.36e-04 | 30 | 47 | 3 | MP:0011346 | |
| MousePheno | delayed inner ear development | 1.65e-04 | 6 | 47 | 2 | MP:0004664 | |
| MousePheno | polar cataract | 1.65e-04 | 6 | 47 | 2 | MP:0010258 | |
| MousePheno | abnormal glomerular mesangium morphology | 1.70e-04 | 83 | 47 | 4 | MP:0011339 | |
| MousePheno | renal cast | 1.98e-04 | 34 | 47 | 3 | MP:0011402 | |
| MousePheno | podocyte microvillus transformation | 2.30e-04 | 7 | 47 | 2 | MP:0011868 | |
| MousePheno | abnormal capillary morphology | 2.63e-04 | 93 | 47 | 4 | MP:0003658 | |
| MousePheno | macrophthalmia | 3.06e-04 | 8 | 47 | 2 | MP:0001296 | |
| MousePheno | abnormal forelimb morphology | 3.49e-04 | 182 | 47 | 5 | MP:0000550 | |
| MousePheno | abnormal long bone morphology | TGFBR3 COL9A2 COL11A1 PAX8 COL27A1 ADAMTS17 DUOX2 PBXIP1 ALPL | 3.58e-04 | 676 | 47 | 9 | MP:0003723 |
| MousePheno | abnormal epiphyseal plate morphology | 3.76e-04 | 185 | 47 | 5 | MP:0006395 | |
| MousePheno | abnormal glomerular capsule parietal layer morphology | 3.92e-04 | 9 | 47 | 2 | MP:0011498 | |
| MousePheno | dilated glomerular capillary | 3.92e-04 | 9 | 47 | 2 | MP:0011509 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 4.28e-04 | 44 | 47 | 3 | MP:0011348 | |
| MousePheno | abnormal renal glomerular capsule morphology | 4.49e-04 | 107 | 47 | 4 | MP:0002828 | |
| MousePheno | expanded mesangial matrix | 4.89e-04 | 46 | 47 | 3 | MP:0011353 | |
| MousePheno | decreased cornea stroma thickness | 4.89e-04 | 10 | 47 | 2 | MP:0003092 | |
| MousePheno | abnormal systemic artery morphology | 5.10e-04 | 304 | 47 | 6 | MP:0011655 | |
| MousePheno | abnormal hindlimb morphology | 6.01e-04 | 576 | 47 | 8 | MP:0000556 | |
| MousePheno | decreased bone mineralization | 6.62e-04 | 51 | 47 | 3 | MP:0020137 | |
| MousePheno | abnormal mesangial matrix morphology | 6.62e-04 | 51 | 47 | 3 | MP:0011338 | |
| MousePheno | abnormal aortic arch morphology | 6.71e-04 | 119 | 47 | 4 | MP:0004113 | |
| MousePheno | abnormal skeletal muscle fiber morphology | 6.99e-04 | 212 | 47 | 5 | MP:0003084 | |
| MousePheno | limbs/digits/tail phenotype | COL4A2 TGFBR3 FLNC CACNB1 COL9A2 COL11A1 PAX8 COL27A1 ADAMTS17 DUOX2 ITGB1 PBXIP1 | 7.15e-04 | 1258 | 47 | 12 | MP:0005371 |
| MousePheno | abnormal inner ear development | 7.15e-04 | 12 | 47 | 2 | MP:0011238 | |
| MousePheno | abnormal femur morphology | 7.30e-04 | 214 | 47 | 5 | MP:0000559 | |
| MousePheno | kidney atrophy | 7.42e-04 | 53 | 47 | 3 | MP:0004970 | |
| MousePheno | abnormal hindlimb stylopod morphology | 7.45e-04 | 215 | 47 | 5 | MP:0003856 | |
| MousePheno | renal interstitial fibrosis | 7.83e-04 | 54 | 47 | 3 | MP:0003215 | |
| MousePheno | dilated capillary | 8.43e-04 | 13 | 47 | 2 | MP:0020326 | |
| MousePheno | abnormal thyroid gland development | 8.43e-04 | 13 | 47 | 2 | MP:0003421 | |
| MousePheno | total cataract | 8.43e-04 | 13 | 47 | 2 | MP:0010263 | |
| MousePheno | decreased skeletal muscle mass | 9.62e-04 | 131 | 47 | 4 | MP:0004819 | |
| MousePheno | abnormal thoracic aorta morphology | 1.05e-03 | 134 | 47 | 4 | MP:0010468 | |
| MousePheno | abnormal podocyte slit diaphragm morphology | 1.29e-03 | 16 | 47 | 2 | MP:0008060 | |
| MousePheno | abnormal collagen level | 1.29e-03 | 16 | 47 | 2 | MP:0020252 | |
| MousePheno | increased circulating thyroid-stimulating hormone level | 1.46e-03 | 17 | 47 | 2 | MP:0005122 | |
| MousePheno | abnormal kidney interstitium morphology | 1.47e-03 | 67 | 47 | 3 | MP:0011425 | |
| MousePheno | hemorrhage | 1.51e-03 | 664 | 47 | 8 | MP:0001914 | |
| MousePheno | glomerulosclerosis | 1.53e-03 | 68 | 47 | 3 | MP:0005264 | |
| MousePheno | increased urine protein level | 1.55e-03 | 149 | 47 | 4 | MP:0002962 | |
| MousePheno | abnormal skeletal muscle mass | 1.55e-03 | 149 | 47 | 4 | MP:0004817 | |
| MousePheno | abnormal fetal ductus arteriosus morphology | 1.64e-03 | 18 | 47 | 2 | MP:0010564 | |
| MousePheno | abnormal podocyte slit junction morphology | 1.64e-03 | 18 | 47 | 2 | MP:0008062 | |
| MousePheno | dilated vasculature | 1.67e-03 | 70 | 47 | 3 | MP:0004938 | |
| MousePheno | ventricular septal defect | 1.77e-03 | 261 | 47 | 5 | MP:0010402 | |
| MousePheno | increased circulating triglyceride level | 1.80e-03 | 262 | 47 | 5 | MP:0001552 | |
| MousePheno | glomerular crescent | 1.82e-03 | 19 | 47 | 2 | MP:0011506 | |
| MousePheno | abnormal cornea size | 1.95e-03 | 74 | 47 | 3 | MP:0031498 | |
| MousePheno | abnormal cornea thickness | 1.95e-03 | 74 | 47 | 3 | MP:0011961 | |
| MousePheno | abnormal circulating total protein level | 2.02e-03 | 269 | 47 | 5 | MP:0011888 | |
| MousePheno | increased thyroid-stimulating hormone level | 2.02e-03 | 20 | 47 | 2 | MP:0005135 | |
| MousePheno | arteriovenous malformation | 2.02e-03 | 20 | 47 | 2 | MP:0006093 | |
| MousePheno | thin dermal layer | 2.02e-03 | 20 | 47 | 2 | MP:0001244 | |
| MousePheno | abnormal lens capsule morphology | 2.02e-03 | 20 | 47 | 2 | MP:0003236 | |
| MousePheno | muscular ventricular septal defect | 2.19e-03 | 77 | 47 | 3 | MP:0010420 | |
| MousePheno | decreased cornea thickness | 2.23e-03 | 21 | 47 | 2 | MP:0005543 | |
| MousePheno | decreased activity of thyroid gland | 2.23e-03 | 21 | 47 | 2 | MP:0003503 | |
| MousePheno | decreased skeletal muscle fiber number | 2.23e-03 | 21 | 47 | 2 | MP:0009406 | |
| MousePheno | abnormal muscle fiber morphology | 2.27e-03 | 406 | 47 | 6 | MP:0004087 | |
| MousePheno | abnormal lens development | 2.27e-03 | 78 | 47 | 3 | MP:0005545 | |
| MousePheno | renal fibrosis | 2.27e-03 | 78 | 47 | 3 | MP:0003985 | |
| MousePheno | decreased length of long bones | 2.35e-03 | 409 | 47 | 6 | MP:0004686 | |
| MousePheno | abnormal interventricular septum muscular part morphology | 2.36e-03 | 79 | 47 | 3 | MP:0010498 | |
| MousePheno | abnormal kidney size | 2.39e-03 | 714 | 47 | 8 | MP:0002706 | |
| MousePheno | small thyroid gland | 2.45e-03 | 22 | 47 | 2 | MP:0002951 | |
| MousePheno | abnormal urine protein level | 2.51e-03 | 170 | 47 | 4 | MP:0006315 | |
| MousePheno | kidney inflammation | 2.56e-03 | 171 | 47 | 4 | MP:0001859 | |
| MousePheno | abnormal axial skeleton morphology | COL4A2 TGFBR3 COL5A2 CACNB1 COL11A1 PAX8 COL27A1 ADAMTS17 ITGB1 PBXIP1 PRRC2B ALPL | 2.58e-03 | 1458 | 47 | 12 | MP:0002114 |
| MousePheno | abnormal long bone epiphyseal plate morphology | 2.61e-03 | 172 | 47 | 4 | MP:0003055 | |
| MousePheno | abnormal appendicular skeleton morphology | TGFBR3 COL9A2 COL11A1 PAX8 COL27A1 ADAMTS17 DUOX2 PBXIP1 ALPL | 2.63e-03 | 896 | 47 | 9 | MP:0009250 |
| MousePheno | abnormal thyroid follicle morphology | 2.68e-03 | 23 | 47 | 2 | MP:0004696 | |
| MousePheno | abnormal skin physiology | 2.71e-03 | 288 | 47 | 5 | MP:0005501 | |
| MousePheno | abnormal chondrocyte morphology | 2.71e-03 | 83 | 47 | 3 | MP:0000166 | |
| MousePheno | increased blood urea nitrogen level | 2.75e-03 | 289 | 47 | 5 | MP:0005565 | |
| MousePheno | abnormal craniofacial development | 2.85e-03 | 425 | 47 | 6 | MP:0003935 | |
| MousePheno | tubulointerstitial nephritis | 2.91e-03 | 24 | 47 | 2 | MP:0011405 | |
| MousePheno | renal/urinary system inflammation | 3.08e-03 | 180 | 47 | 4 | MP:0011762 | |
| MousePheno | abnormal muscle development | 3.10e-03 | 87 | 47 | 3 | MP:0000733 | |
| MousePheno | abnormal hypodermis morphology | 3.14e-03 | 181 | 47 | 4 | MP:0003705 | |
| Domain | Collagen | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 MBL2 COL5A3 COL22A1 EMILIN1 MARCO | 2.75e-39 | 85 | 62 | 23 | IPR008160 |
| Domain | Collagen | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 MBL2 COL5A3 COL22A1 EMILIN1 MARCO | 2.75e-39 | 85 | 62 | 23 | PF01391 |
| Domain | TSPN | COL5A1 COL24A1 COL11A1 COL16A1 COL21A1 COL27A1 COL5A3 COL22A1 | 4.35e-15 | 23 | 62 | 8 | SM00210 |
| Domain | Laminin_G | COL5A1 COL24A1 COL11A1 COL16A1 NRXN2 COL21A1 COL27A1 COL5A3 COL22A1 | 2.51e-13 | 58 | 62 | 9 | IPR001791 |
| Domain | Fib_collagen_C | 4.76e-13 | 11 | 62 | 6 | IPR000885 | |
| Domain | COLFI | 4.76e-13 | 11 | 62 | 6 | PF01410 | |
| Domain | NC1_FIB | 4.76e-13 | 11 | 62 | 6 | PS51461 | |
| Domain | Fib_collagen_C | 4.76e-13 | 11 | 62 | 6 | PD002078 | |
| Domain | COLFI | 4.76e-13 | 11 | 62 | 6 | SM00038 | |
| Domain | C4 | 2.05e-12 | 6 | 62 | 5 | SM00111 | |
| Domain | - | 2.05e-12 | 6 | 62 | 5 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.05e-12 | 6 | 62 | 5 | IPR001442 | |
| Domain | C4 | 2.05e-12 | 6 | 62 | 5 | PF01413 | |
| Domain | NC1_IV | 2.05e-12 | 6 | 62 | 5 | PS51403 | |
| Domain | ConA-like_dom | COL5A1 COL24A1 COL11A1 COL16A1 NRXN2 COL21A1 COL27A1 COL5A3 COL22A1 MEFV | 2.53e-09 | 219 | 62 | 10 | IPR013320 |
| Domain | - | 4.74e-09 | 74 | 62 | 7 | 3.40.50.410 | |
| Domain | VWFA | 9.81e-09 | 82 | 62 | 7 | PS50234 | |
| Domain | VWA | 1.16e-08 | 84 | 62 | 7 | SM00327 | |
| Domain | - | 2.76e-08 | 95 | 62 | 7 | 2.60.120.200 | |
| Domain | VWF_A | 3.67e-08 | 99 | 62 | 7 | IPR002035 | |
| Domain | Laminin_G_2 | 2.06e-07 | 40 | 62 | 5 | PF02210 | |
| Domain | VWA | 1.15e-06 | 56 | 62 | 5 | PF00092 | |
| Domain | CTDL_fold | 1.45e-06 | 107 | 62 | 6 | IPR016187 | |
| Domain | LAM_G_DOMAIN | 7.47e-06 | 38 | 62 | 4 | PS50025 | |
| Domain | LamG | 1.35e-05 | 44 | 62 | 4 | SM00282 | |
| Domain | - | 1.60e-03 | 18 | 62 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 1.60e-03 | 18 | 62 | 2 | IPR020901 | |
| Domain | KU | 1.60e-03 | 18 | 62 | 2 | SM00131 | |
| Domain | BPTI_KUNITZ_2 | 1.79e-03 | 19 | 62 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 1.79e-03 | 19 | 62 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 1.79e-03 | 19 | 62 | 2 | PS00280 | |
| Domain | Kunitz_BPTI | 2.62e-03 | 23 | 62 | 2 | IPR002223 | |
| Domain | Guanylate_kin | 3.35e-03 | 26 | 62 | 2 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 3.35e-03 | 26 | 62 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 3.35e-03 | 26 | 62 | 2 | IPR008144 | |
| Domain | GuKc | 3.35e-03 | 26 | 62 | 2 | SM00072 | |
| Domain | C1Q | 5.04e-03 | 32 | 62 | 2 | SM00110 | |
| Domain | C1q | 5.04e-03 | 32 | 62 | 2 | PF00386 | |
| Domain | C1q_dom | 5.68e-03 | 34 | 62 | 2 | IPR001073 | |
| Domain | C1Q | 5.68e-03 | 34 | 62 | 2 | PS50871 | |
| Domain | KH_1 | 7.06e-03 | 38 | 62 | 2 | PF00013 | |
| Domain | KH | 7.80e-03 | 40 | 62 | 2 | SM00322 | |
| Domain | KH_dom | 7.80e-03 | 40 | 62 | 2 | IPR004087 | |
| Domain | KH_TYPE_1 | 8.57e-03 | 42 | 62 | 2 | PS50084 | |
| Domain | KH_dom_type_1 | 9.38e-03 | 44 | 62 | 2 | IPR004088 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 COL5A3 COL22A1 | 2.03e-39 | 44 | 50 | 20 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 COL5A3 COL22A1 | 6.37e-35 | 67 | 50 | 20 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL28A1 COL5A3 COL22A1 | 1.48e-32 | 41 | 50 | 17 | MM15538 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 COL5A3 COL22A1 | 5.35e-32 | 90 | 50 | 20 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL28A1 COL5A3 COL22A1 | 5.02e-29 | 61 | 50 | 17 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL28A1 COL5A3 COL22A1 | 3.46e-27 | 76 | 50 | 17 | MM14573 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL6A6 COL27A1 COL5A3 | 7.82e-27 | 61 | 50 | 16 | M27103 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL5A3 | 2.44e-24 | 64 | 50 | 15 | M26953 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 COL5A3 COL22A1 ITGB1 EMILIN1 | 3.95e-24 | 300 | 50 | 22 | M610 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL6A6 COL5A3 | 5.79e-24 | 50 | 50 | 14 | MM14796 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL9A3 COL16A1 COL6A6 COL5A3 ITGB1 | 4.23e-23 | 76 | 50 | 15 | MM14867 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL6A6 COL5A3 | 5.62e-23 | 20 | 50 | 11 | MM15061 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL9A3 COL16A1 COL6A6 COL5A3 ITGB1 | 2.62e-22 | 85 | 50 | 15 | M16441 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL28A1 COL5A3 COL22A1 ITGB1 EMILIN1 | 9.15e-21 | 258 | 50 | 19 | MM14572 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL5A2 COL6A3 CACNB1 COL9A2 COL9A3 COL6A6 COL5A3 | 9.73e-21 | 42 | 50 | 12 | M7169 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 | 3.39e-20 | 46 | 50 | 12 | M198 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL11A1 COL6A6 COL5A3 | 2.28e-19 | 53 | 50 | 12 | MM14566 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL6A6 COL5A3 ITGB1 | 3.35e-19 | 76 | 50 | 13 | M27219 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL6A6 COL5A3 | 3.85e-19 | 38 | 50 | 11 | MM14969 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL5A3 | 7.01e-19 | 140 | 50 | 15 | M587 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL5A2 COL6A3 CACNB1 COL9A2 COL9A3 COL6A6 COL5A3 | 2.23e-18 | 63 | 50 | 12 | M11187 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL11A1 COL5A3 ITGB1 | 7.35e-18 | 32 | 50 | 10 | MM14924 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 | 1.78e-17 | 74 | 50 | 12 | M160 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL6A6 COL5A3 | 5.62e-17 | 57 | 50 | 11 | MM14713 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL6A6 COL5A3 | 6.92e-17 | 58 | 50 | 11 | M2049 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL8A2 COL11A1 COL6A6 COL5A3 | 4.06e-15 | 114 | 50 | 12 | MM14571 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL11A1 COL5A3 ITGB1 | 6.68e-15 | 59 | 50 | 10 | M27218 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | COL4A1 COL4A2 COL4A6 COL5A1 COL5A2 COL6A3 COL11A1 COL6A6 COL5A3 ITGB1 | 2.75e-13 | 84 | 50 | 10 | M7098 |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.03e-13 | 10 | 50 | 6 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.03e-13 | 10 | 50 | 6 | MM1560 | |
| Pathway | PID_INTEGRIN1_PATHWAY | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL11A1 ITGB1 | 1.32e-12 | 66 | 50 | 9 | M18 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.94e-12 | 47 | 50 | 8 | MM14925 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.13e-12 | 15 | 50 | 6 | MM14922 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 8.72e-12 | 30 | 50 | 7 | M27772 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A1 COL4A2 COL4A3 COL4A5 TGFBR3 COL5A1 COL5A2 COL24A1 COL6A3 COL9A2 COL9A3 COL11A1 COL6A6 COL27A1 COL5A3 ITGB1 | 2.03e-11 | 532 | 50 | 16 | M27870 |
| Pathway | KEGG_FOCAL_ADHESION | COL4A1 COL4A2 COL4A6 COL5A1 COL5A2 COL6A3 FLNC COL11A1 COL6A6 COL5A3 ITGB1 | 7.77e-11 | 199 | 50 | 11 | M7253 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL6A6 COL5A3 ITGB1 | 8.20e-11 | 261 | 50 | 12 | MM15676 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 9.35e-11 | 41 | 50 | 7 | M27778 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A1 COL4A2 COL4A3 COL4A5 TGFBR3 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL11A1 COL6A6 COL5A3 ITGB1 | 1.16e-10 | 418 | 50 | 14 | MM15587 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.08e-10 | 11 | 50 | 5 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 3.55e-10 | 12 | 50 | 5 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 5.76e-10 | 13 | 50 | 5 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 5.76e-10 | 13 | 50 | 5 | M12950 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 8.13e-10 | 30 | 50 | 6 | M27216 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 8.93e-10 | 14 | 50 | 5 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 8.93e-10 | 14 | 50 | 5 | M6487 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.34e-09 | 15 | 50 | 5 | M27161 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.78e-09 | 18 | 50 | 5 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 3.78e-09 | 18 | 50 | 5 | MM14882 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.12e-09 | 19 | 50 | 5 | MM15512 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 6.81e-09 | 20 | 50 | 5 | M15394 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 8.06e-09 | 43 | 50 | 6 | M39565 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.09e-08 | 79 | 50 | 7 | M27643 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.47e-08 | 23 | 50 | 5 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.47e-08 | 23 | 50 | 5 | MM1427 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.09e-08 | 30 | 50 | 5 | MM15517 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL5A2 COL6A3 CACNB1 COL9A2 COL9A3 COL6A6 COL5A3 ITGB1 | 6.68e-08 | 575 | 50 | 13 | M29853 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL6A6 COL5A3 ITGB1 | 1.29e-07 | 502 | 50 | 12 | MM14537 |
| Pathway | WP_PI3KAKT_SIGNALING | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL6A3 COL9A2 COL9A3 COL6A6 ITGB1 | 2.48e-07 | 339 | 50 | 10 | M39736 |
| Pathway | WP_FOCAL_ADHESION | 2.75e-07 | 187 | 50 | 8 | MM15913 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.06e-06 | 96 | 50 | 6 | M39834 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.31e-06 | 27 | 50 | 4 | M27217 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.74e-06 | 67 | 50 | 5 | MM15345 | |
| Pathway | WP_FOCAL_ADHESION | 6.01e-06 | 199 | 50 | 7 | M39402 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 9.93e-06 | 302 | 50 | 8 | M39719 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.56e-05 | 43 | 50 | 4 | M53 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.73e-05 | 326 | 50 | 8 | MM15917 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 3.91e-05 | 19 | 50 | 3 | M27221 | |
| Pathway | WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES | 1.83e-04 | 6 | 50 | 2 | M39872 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.19e-04 | 84 | 50 | 4 | M3228 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.55e-04 | 161 | 50 | 5 | M39770 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A1 COL4A2 COL4A3 COL4A5 COL5A1 COL5A2 COL6A3 CACNB1 COL9A2 COL9A3 COL6A6 PAX8 COL5A3 ITGB1 | 3.26e-04 | 1432 | 50 | 14 | M509 |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 8.50e-04 | 439 | 50 | 7 | M42563 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4 | 1.82e-03 | 18 | 50 | 2 | M39327 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 1.82e-03 | 18 | 50 | 2 | MM15123 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 1.82e-03 | 18 | 50 | 2 | M840 | |
| Pathway | WP_CANCER_PATHWAYS | 1.95e-03 | 507 | 50 | 7 | M48302 | |
| Pathway | WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS | 2.03e-03 | 19 | 50 | 2 | M39473 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.11e-03 | 72 | 50 | 3 | M39403 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 2.19e-03 | 155 | 50 | 4 | M522 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.19e-03 | 73 | 50 | 3 | MM15906 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.19e-03 | 73 | 50 | 3 | MM15126 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 4.09e-03 | 27 | 50 | 2 | M45550 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 4.39e-03 | 28 | 50 | 2 | MM15957 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 4.76e-03 | 96 | 50 | 3 | MM14592 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 5.04e-03 | 98 | 50 | 3 | M27152 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.71e-03 | 32 | 50 | 2 | MM14854 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 5.72e-03 | 325 | 50 | 5 | M12868 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 7.59e-03 | 37 | 50 | 2 | M27134 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 7.99e-03 | 38 | 50 | 2 | MM14874 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 8.23e-03 | 117 | 50 | 3 | M19248 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 8.40e-03 | 39 | 50 | 2 | MM14601 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL5A3 EMILIN1 | 3.16e-27 | 135 | 63 | 17 | 28675934 |
| Pubmed | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL9A2 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 COL22A1 EMILIN1 | 3.71e-27 | 175 | 63 | 18 | 28071719 | |
| Pubmed | COL4A1 COL4A2 COL4A3 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL16A1 COL6A6 COL21A1 COL28A1 EMILIN1 | 2.70e-24 | 153 | 63 | 16 | 25037231 | |
| Pubmed | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL9A3 COL16A1 COL28A1 COL27A1 ADAMTS17 COL5A3 EMILIN1 | 8.75e-22 | 167 | 63 | 15 | 22159717 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL16A1 COL27A1 COL5A3 | 1.79e-17 | 62 | 63 | 10 | 28344315 |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 9.93e-14 | 6 | 63 | 5 | 9506531 | |
| Pubmed | 9.93e-14 | 6 | 63 | 5 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 9.93e-14 | 6 | 63 | 5 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 9.93e-14 | 6 | 63 | 5 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 9.93e-14 | 6 | 63 | 5 | 6389236 | |
| Pubmed | 9.93e-14 | 6 | 63 | 5 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 9.93e-14 | 6 | 63 | 5 | 10534397 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 9.93e-14 | 6 | 63 | 5 | 9673377 | |
| Pubmed | 9.93e-14 | 6 | 63 | 5 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 9.93e-14 | 6 | 63 | 5 | 19275937 | |
| Pubmed | 9.93e-14 | 6 | 63 | 5 | 6988303 | ||
| Pubmed | 3.47e-13 | 7 | 63 | 5 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 3.47e-13 | 7 | 63 | 5 | 8006028 | |
| Pubmed | 3.47e-13 | 7 | 63 | 5 | 10416788 | ||
| Pubmed | 3.47e-13 | 7 | 63 | 5 | 1724753 | ||
| Pubmed | 3.47e-13 | 7 | 63 | 5 | 7521231 | ||
| Pubmed | 9.25e-13 | 8 | 63 | 5 | 3997552 | ||
| Pubmed | 9.25e-13 | 8 | 63 | 5 | 29422532 | ||
| Pubmed | 9.25e-13 | 8 | 63 | 5 | 1377218 | ||
| Pubmed | 9.25e-13 | 8 | 63 | 5 | 10382266 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 9.25e-13 | 8 | 63 | 5 | 10970885 | |
| Pubmed | 1.47e-12 | 21 | 63 | 6 | 23325811 | ||
| Pubmed | 2.08e-12 | 9 | 63 | 5 | 9878537 | ||
| Pubmed | 2.08e-12 | 9 | 63 | 5 | 12101409 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 3.47e-12 | 86 | 63 | 8 | 28327460 | |
| Pubmed | 4.15e-12 | 10 | 63 | 5 | 9136074 | ||
| Pubmed | 4.26e-12 | 50 | 63 | 7 | 23658023 | ||
| Pubmed | COL4A3 COL4A6 COL5A1 COL5A2 COL9A2 COL11A1 COL16A1 COL5A3 TFIP11 ALPL | 5.02e-12 | 210 | 63 | 10 | 16537572 | |
| Pubmed | 6.19e-12 | 26 | 63 | 6 | 24742657 | ||
| Pubmed | 7.60e-12 | 11 | 63 | 5 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 7.60e-12 | 11 | 63 | 5 | 7500359 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 9.31e-12 | 97 | 63 | 8 | 27559042 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.30e-11 | 12 | 63 | 5 | 12180907 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 1.30e-11 | 12 | 63 | 5 | 15837576 | |
| Pubmed | 1.30e-11 | 12 | 63 | 5 | 16024816 | ||
| Pubmed | 3.28e-11 | 14 | 63 | 5 | 12878203 | ||
| Pubmed | 7.13e-11 | 16 | 63 | 5 | 15878328 | ||
| Pubmed | 8.61e-11 | 39 | 63 | 6 | 33580754 | ||
| Pubmed | 1.01e-10 | 40 | 63 | 6 | 27068110 | ||
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 7495302 | ||
| Pubmed | 1.46e-10 | 6 | 63 | 4 | 10722718 | ||
| Pubmed | 1.89e-10 | 19 | 63 | 5 | 15689378 | ||
| Pubmed | 3.41e-10 | 7 | 63 | 4 | 10639489 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 3.41e-10 | 7 | 63 | 4 | 10716744 | |
| Pubmed | 3.41e-10 | 7 | 63 | 4 | 17418794 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 6.80e-10 | 8 | 63 | 4 | 20059976 | |
| Pubmed | 8.57e-10 | 25 | 63 | 5 | 19180518 | ||
| Pubmed | 1.22e-09 | 9 | 63 | 4 | 8562707 | ||
| Pubmed | 1.73e-09 | 186 | 63 | 8 | 20673868 | ||
| Pubmed | 1.73e-09 | 186 | 63 | 8 | 20452482 | ||
| Pubmed | 2.04e-09 | 10 | 63 | 4 | 9415455 | ||
| Pubmed | 2.04e-09 | 10 | 63 | 4 | 2446864 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 2.04e-09 | 10 | 63 | 4 | 15345741 | |
| Pubmed | 2.72e-09 | 31 | 63 | 5 | 22925884 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 3.19e-09 | 11 | 63 | 4 | 9731539 | |
| Pubmed | 3.22e-09 | 32 | 63 | 5 | 23154389 | ||
| Pubmed | 4.79e-09 | 12 | 63 | 4 | 8918877 | ||
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 3025878 | ||
| Pubmed | The role of polymorphisms of genes encoding collagen IX and XI in lumbar disc disease. | 5.66e-09 | 3 | 63 | 3 | 24636772 | |
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 37158802 | ||
| Pubmed | Identification of an Altered Matrix Signature in Kidney Aging and Disease. | 5.66e-09 | 3 | 63 | 3 | 34049963 | |
| Pubmed | 5.66e-09 | 3 | 63 | 3 | 6386565 | ||
| Pubmed | Isolation of the alpha 3-chain of human type V collagen and characterization by partial sequencing. | 5.66e-09 | 3 | 63 | 3 | 1571108 | |
| Pubmed | Biosynthetic processing of the Pro-alpha1(V)Pro-alpha2(V)Pro-alpha3(V) procollagen heterotrimer. | 5.66e-09 | 3 | 63 | 3 | 15136578 | |
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 5.66e-09 | 3 | 63 | 3 | 27377778 | |
| Pubmed | cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1). | 5.66e-09 | 3 | 63 | 3 | 9582436 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 6.90e-09 | 13 | 63 | 4 | 9833687 | |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 6.90e-09 | 13 | 63 | 4 | 36335435 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 6.94e-09 | 79 | 63 | 6 | 18757743 | |
| Pubmed | 9.03e-09 | 146 | 63 | 7 | 27068509 | ||
| Pubmed | 9.65e-09 | 14 | 63 | 4 | 19858219 | ||
| Pubmed | 1.31e-08 | 15 | 63 | 4 | 10625553 | ||
| Pubmed | 1.31e-08 | 15 | 63 | 4 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 1.31e-08 | 15 | 63 | 4 | 10706142 | |
| Pubmed | 1.75e-08 | 16 | 63 | 4 | 17881772 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 2.26e-08 | 4 | 63 | 3 | 7827955 | |
| Pubmed | 2.26e-08 | 4 | 63 | 3 | 23818951 | ||
| Pubmed | 2.93e-08 | 18 | 63 | 4 | 9160753 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 3.07e-08 | 101 | 63 | 6 | 20551380 | |
| Pubmed | 5.65e-08 | 5 | 63 | 3 | 9409248 | ||
| Pubmed | Expression patterns of cartilage collagens and Sox9 during mouse heart development. | 1.13e-07 | 6 | 63 | 3 | 12883905 | |
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 20301479 | ||
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 21467034 | ||
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 16041630 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 1.13e-07 | 6 | 63 | 3 | 8563024 | |
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 17876790 | ||
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 15922184 | ||
| Pubmed | 2.24e-07 | 29 | 63 | 4 | 22613833 | ||
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 15872058 | ||
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 1383086 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 3.15e-07 | 8 | 63 | 3 | 11867580 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 3.15e-07 | 8 | 63 | 3 | 33875569 | |
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 9164858 | ||
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 18816857 | ||
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 11683410 | ||
| Interaction | COLGALT2 interactions | 3.25e-11 | 67 | 63 | 8 | int:COLGALT2 | |
| Interaction | CD93 interactions | 8.55e-11 | 45 | 63 | 7 | int:CD93 | |
| Interaction | LAIR2 interactions | 1.60e-10 | 49 | 63 | 7 | int:LAIR2 | |
| Interaction | MMP9 interactions | 1.55e-09 | 67 | 63 | 7 | int:MMP9 | |
| Interaction | HABP2 interactions | 2.11e-09 | 18 | 63 | 5 | int:HABP2 | |
| Interaction | OSM interactions | 3.80e-09 | 20 | 63 | 5 | int:OSM | |
| Interaction | PLOD3 interactions | COL4A1 COL4A2 COL4A6 COL9A2 COL9A3 COL16A1 COL21A1 MARCO PRRC2B | 5.35e-09 | 183 | 63 | 9 | int:PLOD3 |
| Interaction | MMP2 interactions | 9.94e-09 | 87 | 63 | 7 | int:MMP2 | |
| Interaction | COL2A1 interactions | 4.76e-08 | 64 | 63 | 6 | int:COL2A1 | |
| Interaction | COL4A2 interactions | 1.24e-07 | 75 | 63 | 6 | int:COL4A2 | |
| Interaction | COL8A2 interactions | 1.98e-07 | 42 | 63 | 5 | int:COL8A2 | |
| Interaction | DCN interactions | 2.23e-07 | 43 | 63 | 5 | int:DCN | |
| Interaction | PLOD1 interactions | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL9A3 COL16A1 COL21A1 PRRC2B | 2.97e-07 | 292 | 63 | 9 | int:PLOD1 |
| Interaction | C1QTNF1 interactions | 3.52e-07 | 47 | 63 | 5 | int:C1QTNF1 | |
| Interaction | SERPINE2 interactions | 8.58e-07 | 56 | 63 | 5 | int:SERPINE2 | |
| Interaction | COL5A1 interactions | 1.82e-06 | 65 | 63 | 5 | int:COL5A1 | |
| Interaction | MAG interactions | 1.94e-06 | 29 | 63 | 4 | int:MAG | |
| Interaction | FBLN2 interactions | 1.96e-06 | 66 | 63 | 5 | int:FBLN2 | |
| Interaction | PRNP interactions | MAGI2 COL5A2 COL24A1 FLNC COL8A2 COL9A2 TNRC18 COL11A1 COL16A1 MDN1 MATR3 COL22A1 PRRC2B KHSRP | 1.04e-05 | 1158 | 63 | 14 | int:PRNP |
| Interaction | FN1 interactions | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 FLNC COL8A2 MDN1 GAR1 MATR3 ITGB1 KHSRP | 1.05e-05 | 848 | 63 | 12 | int:FN1 |
| Interaction | MATN2 interactions | 2.75e-05 | 113 | 63 | 5 | int:MATN2 | |
| Interaction | TGFBI interactions | 6.38e-05 | 25 | 63 | 3 | int:TGFBI | |
| Interaction | COL5A2 interactions | 1.00e-04 | 29 | 63 | 3 | int:COL5A2 | |
| Interaction | ANTXR2 interactions | 1.00e-04 | 29 | 63 | 3 | int:ANTXR2 | |
| Interaction | COL1A2 interactions | 1.04e-04 | 78 | 63 | 4 | int:COL1A2 | |
| Interaction | BMP3 interactions | 2.66e-04 | 8 | 63 | 2 | int:BMP3 | |
| Interaction | ANXA7 interactions | 2.75e-04 | 184 | 63 | 5 | int:ANXA7 | |
| Interaction | FUBP3 interactions | 3.27e-04 | 297 | 63 | 6 | int:FUBP3 | |
| Interaction | ADAMTS5 interactions | 3.41e-04 | 9 | 63 | 2 | int:ADAMTS5 | |
| Interaction | COL21A1 interactions | 3.41e-04 | 9 | 63 | 2 | int:COL21A1 | |
| Interaction | DISC1 interactions | 3.74e-04 | 429 | 63 | 7 | int:DISC1 | |
| Interaction | COL5A3 interactions | 4.26e-04 | 10 | 63 | 2 | int:COL5A3 | |
| Interaction | NRON interactions | 4.26e-04 | 10 | 63 | 2 | int:NRON | |
| Cytoband | 1p33-p32 | 6.63e-05 | 9 | 63 | 2 | 1p33-p32 | |
| Cytoband | Xq22 | 4.21e-04 | 22 | 63 | 2 | Xq22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 1.74e-03 | 172 | 63 | 3 | chrXq22 | |
| Cytoband | 13q34 | 2.53e-03 | 54 | 63 | 2 | 13q34 | |
| GeneFamily | Collagens | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 COL5A3 COL22A1 | 9.31e-42 | 46 | 47 | 20 | 490 |
| GeneFamily | Collagens|Collagen proteoglycans | 6.58e-05 | 5 | 47 | 2 | 575 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 2.07e-03 | 26 | 47 | 2 | 904 | |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 COL5A3 COL22A1 | 2.39e-42 | 44 | 63 | 20 | M3005 |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 COL22A1 | 6.47e-40 | 43 | 63 | 19 | MM17060 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 COL5A3 COL22A1 EMILIN1 | 2.36e-26 | 275 | 63 | 21 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 COL5A3 COL22A1 EMILIN1 | 8.07e-25 | 270 | 63 | 20 | MM17057 |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL21A1 COL28A1 COL27A1 MBL2 ADAMTS17 COL5A3 COL22A1 EMILIN1 | 7.10e-17 | 1026 | 63 | 23 | M5889 |
| Coexpression | NABA_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL6A6 COL28A1 COL27A1 MBL2 ADAMTS17 COL5A3 COL22A1 EMILIN1 | 6.96e-16 | 1008 | 63 | 22 | MM17056 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | COL4A1 COL4A2 TGFBR3 COL5A1 COL5A2 COL6A3 COL8A2 COL11A1 COL16A1 COL5A3 ITGB1 | 1.69e-12 | 200 | 63 | 11 | M5930 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.75e-12 | 40 | 63 | 7 | M5887 | |
| Coexpression | GU_PDEF_TARGETS_UP | 6.64e-12 | 71 | 63 | 8 | M3955 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL6A3 COL21A1 COL27A1 TCEAL8 ITGB1 EMILIN1 | 1.85e-09 | 385 | 63 | 11 | M39264 |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 2.46e-08 | 74 | 63 | 6 | M13547 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 COL11A1 COL16A1 NRXN2 COL21A1 COL28A1 COL5A3 EMILIN1 ALPL | 2.83e-08 | 767 | 63 | 13 | M39209 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL4A1 COL4A2 COL4A5 COL4A6 TGFBR3 COL5A1 COL5A2 COL6A3 COL27A1 COL5A3 EMILIN1 | 3.04e-08 | 505 | 63 | 11 | M39167 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 4.26e-08 | 81 | 63 | 6 | M39253 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | COL4A1 COL4A2 TGFBR3 COL5A1 COL5A2 FLNC COL9A2 COL16A1 ITGB1 CDH3 | 2.03e-07 | 479 | 63 | 10 | M2573 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | COL4A1 COL4A2 TGFBR3 COL5A1 COL5A2 FLNC COL9A2 COL16A1 ITGB1 CDH3 | 2.19e-07 | 483 | 63 | 10 | MM1082 |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | COL4A1 COL5A1 COL5A2 COL6A3 FLNC COL16A1 COL5A3 TCEAL8 ITGB1 | 2.39e-07 | 369 | 63 | 9 | MM16610 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 2.56e-07 | 268 | 63 | 8 | M45796 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.59e-07 | 23 | 63 | 4 | M48001 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 2.81e-07 | 111 | 63 | 6 | M45685 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_DN | 3.37e-07 | 60 | 63 | 5 | MM761 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_DN | 3.37e-07 | 60 | 63 | 5 | M1797 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 3.84e-07 | 117 | 63 | 6 | M39300 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 8.28e-07 | 313 | 63 | 8 | M40228 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 9.72e-07 | 137 | 63 | 6 | M40313 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 1.99e-06 | 352 | 63 | 8 | M17471 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | COL4A5 COL4A6 NOL4 COL24A1 COL9A2 PAX8 COL27A1 ADAMTS17 DUOX2 DLX4 TCEAL8 KLHL14 PGM5 | 2.01e-06 | 1115 | 63 | 13 | M10371 |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 2.15e-06 | 11 | 63 | 3 | M47997 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | COL4A1 COL4A2 COL4A6 TGFBR3 COL5A1 FLNC COL16A1 COL27A1 PGM5 | 2.63e-06 | 493 | 63 | 9 | M19391 |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 2.71e-06 | 91 | 63 | 5 | M40180 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 3.01e-06 | 93 | 63 | 5 | M4752 | |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 3.18e-06 | 94 | 63 | 5 | M2580 | |
| Coexpression | BENPORATH_PRC2_TARGETS | COL4A5 COL4A6 NOL4 COL24A1 COL9A2 PAX8 COL27A1 DUOX2 DLX4 PGM5 | 3.21e-06 | 650 | 63 | 10 | M8448 |
| Coexpression | LIM_MAMMARY_LUMINAL_MATURE_DN | 3.35e-06 | 95 | 63 | 5 | MM1328 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 3.71e-06 | 97 | 63 | 5 | M45794 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 3.83e-06 | 44 | 63 | 4 | M18274 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 5.45e-06 | 48 | 63 | 4 | M1246 | |
| Coexpression | BENPORATH_EED_TARGETS | MAGI2 COL4A5 COL4A6 NOL4 COL24A1 COL9A2 PAX8 COL27A1 DUOX2 DLX4 TCEAL8 PGM5 | 7.07e-06 | 1059 | 63 | 12 | M7617 |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP | 8.18e-06 | 198 | 63 | 6 | M6232 | |
| Coexpression | KANG_AR_TARGETS_UP | 8.78e-06 | 17 | 63 | 3 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 8.78e-06 | 17 | 63 | 3 | M2223 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 8.78e-06 | 17 | 63 | 3 | M47995 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.05e-05 | 120 | 63 | 5 | M42505 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 1.05e-05 | 18 | 63 | 3 | M47984 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 1.52e-05 | 62 | 63 | 4 | M16774 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.73e-05 | 64 | 63 | 4 | M2572 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.84e-05 | 65 | 63 | 4 | M39309 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.20e-05 | 68 | 63 | 4 | M1373 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.33e-05 | 69 | 63 | 4 | M10165 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.76e-05 | 72 | 63 | 4 | MM1131 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 3.41e-05 | 76 | 63 | 4 | M11825 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 3.71e-05 | 27 | 63 | 3 | M47994 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 4.62e-05 | 29 | 63 | 3 | MM17055 | |
| Coexpression | TSAI_RESPONSE_TO_RADIATION_THERAPY | 6.24e-05 | 32 | 63 | 3 | M308 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 6.86e-05 | 33 | 63 | 3 | M9167 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 8.20e-05 | 35 | 63 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 8.93e-05 | 36 | 63 | 3 | MM1212 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 9.61e-05 | 99 | 63 | 4 | M39152 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 9.97e-05 | 192 | 63 | 5 | M42501 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.05e-04 | 194 | 63 | 5 | M39122 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.12e-04 | 457 | 63 | 7 | M1613 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 1.12e-04 | 316 | 63 | 6 | M2293 | |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_DC_DN | 1.15e-04 | 198 | 63 | 5 | M5208 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP | 1.15e-04 | 198 | 63 | 5 | M5215 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN | 1.15e-04 | 198 | 63 | 5 | M6228 | |
| Coexpression | GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP | 1.15e-04 | 198 | 63 | 5 | M6221 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP | 1.18e-04 | 199 | 63 | 5 | M6235 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP | 1.21e-04 | 200 | 63 | 5 | M7745 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN | 1.21e-04 | 200 | 63 | 5 | M3575 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 1.21e-04 | 200 | 63 | 5 | M5915 | |
| Coexpression | LEIN_CHOROID_PLEXUS_MARKERS | 1.21e-04 | 105 | 63 | 4 | M1719 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 1.26e-04 | 323 | 63 | 6 | MM1066 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 1.32e-04 | 41 | 63 | 3 | M47988 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 1.33e-04 | 470 | 63 | 7 | MM1053 | |
| Coexpression | LEIN_CHOROID_PLEXUS_MARKERS | 1.40e-04 | 109 | 63 | 4 | MM1214 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 1.58e-04 | 337 | 63 | 6 | MM16606 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | COL4A5 COL4A6 NOL4 COL24A1 COL9A2 PAX8 COL27A1 DUOX2 DLX4 PGM5 | 1.68e-04 | 1035 | 63 | 10 | M9898 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE | 1.83e-04 | 117 | 63 | 4 | M45663 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 1.99e-04 | 47 | 63 | 3 | M7585 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 2.12e-04 | 48 | 63 | 3 | M10253 | |
| Coexpression | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN | 2.12e-04 | 48 | 63 | 3 | MM1088 | |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_DN | 2.15e-04 | 122 | 63 | 4 | M10276 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 2.19e-04 | 681 | 63 | 8 | M5314 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 2.19e-04 | 681 | 63 | 8 | M39175 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_UP | 2.39e-04 | 50 | 63 | 3 | M7337 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 2.39e-04 | 50 | 63 | 3 | MM403 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 2.44e-04 | 126 | 63 | 4 | M39132 | |
| Coexpression | WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER | 2.69e-04 | 52 | 63 | 3 | M19766 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 2.71e-04 | 703 | 63 | 8 | MM1055 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COL4A5 COL4A6 TGFBR3 COL6A3 COL11A1 COL16A1 KCNA6 COL27A1 ANKHD1 PSPC1 | 2.79e-04 | 1102 | 63 | 10 | M2369 |
| Coexpression | DESCARTES_ORGANOGENESIS_CONNECTIVE_TISSUE_PROGENITOR | 3.18e-04 | 55 | 63 | 3 | MM3666 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COL4A5 COL4A6 TGFBR3 COL6A3 COL11A1 COL16A1 KCNA6 COL27A1 ANKHD1 PSPC1 | 3.26e-04 | 1124 | 63 | 10 | MM1070 |
| Coexpression | DESCARTES_ORGANOGENESIS_JAW_AND_TOOTH_PROGENITORS | 3.69e-04 | 12 | 63 | 2 | MM3646 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 3.72e-04 | 58 | 63 | 3 | M178 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 3.74e-04 | 141 | 63 | 4 | M10381 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_PERICYTES | 4.05e-04 | 144 | 63 | 4 | M41744 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 4.05e-04 | 144 | 63 | 4 | M5942 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 4.05e-04 | 144 | 63 | 4 | M1484 | |
| Coexpression | LEE_LIVER_CANCER_DENA_UP | 4.11e-04 | 60 | 63 | 3 | M16524 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 4.26e-04 | 146 | 63 | 4 | MM973 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.70e-06 | 197 | 62 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | COL4A3 COL4A5 COL4A6 COL5A1 COL8A2 TNRC18 COL11A1 COL16A1 MATR3 KLHL14 EMILIN1 PGM5 | 2.77e-06 | 797 | 62 | 12 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.30e-06 | 234 | 62 | 7 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 2.25e-05 | 116 | 62 | 5 | ratio_EB_vs_SC_500_K5 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL5A2 FLNC COL9A2 COL9A3 TNRC18 COL11A1 COL27A1 RIPPLY3 | 2.30e-05 | 1153 | 62 | 13 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 2.65e-05 | 300 | 62 | 7 | PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL4A5 COL4A6 FLNC COL9A2 COL11A1 RIPPLY3 ADAMTS17 COL22A1 KLHL14 PBXIP1 PGM5 | 3.04e-05 | 848 | 62 | 11 | ratio_ECTO_vs_SC_2500_K3 |
| CoexpressionAtlas | BM Top 100 - endometrium | 4.15e-05 | 66 | 62 | 4 | BM Top 100 - endometrium | |
| CoexpressionAtlas | BM Top 100 - cervix | 4.15e-05 | 66 | 62 | 4 | BM Top 100 - cervix | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | COL5A2 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL16A1 KCNA6 PBXIP1 TIAM2 PGM5 | 4.18e-05 | 878 | 62 | 11 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.61e-05 | 230 | 62 | 6 | gudmap_developingGonad_P2_epididymis_1000_k2 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL4A1 COL4A2 TGFBR3 COL5A1 COL5A2 COL6A3 COL8A2 COL9A2 COL11A1 RIPPLY3 COL5A3 EMILIN1 | 6.52e-05 | 1094 | 62 | 12 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 8.48e-05 | 489 | 62 | 8 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | COL4A5 COL4A6 COL5A1 COL8A2 COL9A2 TNRC18 COL11A1 COL16A1 EMILIN1 PGM5 | 8.94e-05 | 790 | 62 | 10 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | COL4A5 COL4A6 COL5A1 COL8A2 TNRC18 COL11A1 COL16A1 COL27A1 EMILIN1 PGM5 | 9.82e-05 | 799 | 62 | 10 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.01e-04 | 159 | 62 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | COL24A1 COL6A3 CACNB1 COL8A2 COL9A3 COL16A1 KCNA6 NRXN2 CDH3 PGM5 ALPL | 1.05e-04 | 973 | 62 | 11 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | COL24A1 COL6A3 COL8A2 COL16A1 NRXN2 PAX8 ADAMTS17 CDH3 PGM5 ALPL KHSRP | 1.08e-04 | 976 | 62 | 11 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | COL4A1 COL4A2 COL4A5 COL4A6 TGFBR3 COL5A1 COL5A2 COL9A2 TNRC18 RIPPLY3 PGM5 | 1.14e-04 | 982 | 62 | 11 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.34e-04 | 89 | 62 | 4 | PCBC_ratio_MESO-30_from-OSK-L-l-p53KD_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_episomal_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.34e-04 | 89 | 62 | 4 | PCBC_ratio_MESO-30_from-episomal_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 1.52e-04 | 92 | 62 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | COL5A1 COL5A2 NOL4 FLNC CACNB1 COL9A3 COL11A1 KCNA6 COL6A6 COL27A1 EMILIN1 ALPL | 1.94e-04 | 1228 | 62 | 12 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A2 COL4A5 COL4A6 TGFBR3 COL5A2 FLNC COL9A2 TNRC18 COL11A1 COL22A1 KLHL14 PBXIP1 PRRC2B | 2.63e-04 | 1466 | 62 | 13 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 COL16A1 DUOX2 ITGB1 EMILIN1 | 3.44e-04 | 761 | 62 | 9 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.98e-04 | 330 | 62 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | Endoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | 4.03e-04 | 615 | 62 | 8 | PCBC_ratio_DE_vs_SC_cfr-2X-p05 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K2 | 4.18e-04 | 333 | 62 | 6 | gudmap_RNAseq_e15.5_Podocytes_2500_K2 | |
| CoexpressionAtlas | e10.5_MandibArch_top-relative-expression-ranked_500_5 | 4.54e-04 | 11 | 62 | 2 | Facebase_ST1_e10.5_MandibArch_500_5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | COL24A1 COL6A3 COL8A2 COL9A2 COL16A1 ADAMTS17 UNKL CDH3 PGM5 ALPL | 4.57e-04 | 967 | 62 | 10 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | COL24A1 COL6A3 COL8A2 COL9A2 COL16A1 PAX8 ADAMTS17 CDH3 PGM5 ALPL | 4.60e-04 | 968 | 62 | 10 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | COL24A1 COL6A3 COL8A2 COL16A1 QTRT2 UNKL TFIP11 CDH3 PGM5 ALPL | 4.79e-04 | 973 | 62 | 10 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | COL5A1 COL24A1 COL6A3 COL8A2 COL11A1 COL6A6 PAX8 COL21A1 COL5A3 KLHL14 | 5.11e-04 | 981 | 62 | 10 | Arv_EB-LF_1000 |
| CoexpressionAtlas | placenta | 5.35e-04 | 349 | 62 | 6 | placenta | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSKM - NLT_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 6.26e-04 | 501 | 62 | 7 | PCBC_ratio_MESO-30_from-OSKM - NLT_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 fibroblast_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 6.26e-04 | 501 | 62 | 7 | PCBC_ratio_MESO-30 fibroblast_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_plasmid_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 6.26e-04 | 501 | 62 | 7 | PCBC_ratio_MESO-30_from-plasmid_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | COL5A1 COL5A2 NOL4 FLNC CACNB1 COL9A3 COL11A1 KCNA6 COL6A6 COL27A1 PGM5 | 6.74e-04 | 1208 | 62 | 11 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | thyroid gland | 6.78e-04 | 240 | 62 | 5 | thyroid gland | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.90e-04 | 241 | 62 | 5 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.30e-04 | 244 | 62 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.37e-04 | 371 | 62 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 8.00e-04 | 249 | 62 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#4 | 8.61e-04 | 529 | 62 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.81e-04 | 384 | 62 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#2 | 9.01e-04 | 147 | 62 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.05e-04 | 256 | 62 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.06e-03 | 265 | 62 | 5 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 1.08e-03 | 69 | 62 | 3 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | 1.13e-03 | 70 | 62 | 3 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.17e-03 | 406 | 62 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.19e-03 | 726 | 62 | 8 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 1.22e-03 | 72 | 62 | 3 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.26e-03 | 276 | 62 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | BM Top 100 - thyroid gland | 1.27e-03 | 73 | 62 | 3 | BM Top 100 - thyroid gland | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 1.33e-03 | 74 | 62 | 3 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Endothelial_2500_K4 | 1.46e-03 | 285 | 62 | 5 | gudmap_RNAseq_e15.5_Endothelial_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.57e-03 | 290 | 62 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.63e-03 | 591 | 62 | 7 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | COL5A1 FLNC COL16A1 KCNA6 GAR1 COL6A6 PAX8 KLHL14 EMILIN1 PGM5 | 1.64e-03 | 1143 | 62 | 10 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.75e-03 | 439 | 62 | 6 | GSM777059_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.77e-03 | 298 | 62 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.87e-03 | 445 | 62 | 6 | GSM777043_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | COL24A1 COL6A3 COL8A2 COL9A2 COL16A1 ADAMTS17 CDH3 PGM5 ALPL | 1.88e-03 | 967 | 62 | 9 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | COL24A1 COL6A3 COL8A2 COL9A2 COL16A1 ADAMTS17 CDH3 PGM5 ALPL | 1.88e-03 | 967 | 62 | 9 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | EB bone marrow_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.89e-03 | 446 | 62 | 6 | PCBC_ratio_EB bone marrow_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | COL24A1 COL6A3 COL8A2 COL9A2 COL16A1 ADAMTS17 CDH3 PGM5 ALPL | 1.95e-03 | 972 | 62 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 COL16A1 NRXN2 COL6A6 COL21A1 EMILIN1 | 7.33e-14 | 177 | 63 | 10 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 COL16A1 NRXN2 COL6A6 COL21A1 EMILIN1 | 7.33e-14 | 177 | 63 | 10 | db222faaecbe5600da39277243c4e7e764eb63c9 |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | COL4A1 COL4A2 COL4A3 TGFBR3 COL5A1 COL5A2 COL24A1 COL6A3 ADAMTS17 COL5A3 | 1.66e-13 | 192 | 63 | 10 | 356160b113c3305a61ceeaff33ce3c9da0be2878 |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL6A3 COL11A1 COL16A1 COL27A1 EMILIN1 | 2.15e-13 | 197 | 63 | 10 | 86145bc1e585b4ae136e755cafd6579da2abfa65 |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TGFBR3 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL11A1 COL16A1 COL27A1 EMILIN1 | 2.26e-13 | 198 | 63 | 10 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | TGFBR3 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL11A1 COL16A1 COL27A1 EMILIN1 | 2.26e-13 | 198 | 63 | 10 | 1beed34f469aad07e8f674f0b668d6e1e916403c |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TGFBR3 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL11A1 COL16A1 COL27A1 EMILIN1 | 2.26e-13 | 198 | 63 | 10 | 985022c1722ab7b67675ebe814022a439e715b5e |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL4A1 COL4A2 MAGI2 COL5A1 COL5A2 COL6A3 COL16A1 COL6A6 COL21A1 EMILIN1 | 2.26e-13 | 198 | 63 | 10 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL27A1 ITGB1 EMILIN1 | 2.38e-13 | 199 | 63 | 10 | ec74ff85d6b61013b1f785b2fca343759feb7843 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | COL4A1 COL4A2 MAGI2 COL5A1 COL5A2 COL6A3 COL16A1 COL6A6 COL21A1 EMILIN1 | 2.38e-13 | 199 | 63 | 10 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 FLNC COL16A1 COL6A6 COL5A3 EMILIN1 | 2.38e-13 | 199 | 63 | 10 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL4A2 COL4A5 COL4A6 COL5A1 COL5A2 COL24A1 COL6A3 COL16A1 COL5A3 | 6.24e-12 | 188 | 63 | 9 | b382d18fb09fb2869f3c151efa71540a7f5ed229 |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 COL27A1 EMILIN1 | 6.24e-12 | 188 | 63 | 9 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | COL5A1 COL24A1 COL6A3 COL9A2 COL9A3 COL11A1 COL16A1 COL27A1 EMILIN1 | 6.24e-12 | 188 | 63 | 9 | 7b1e3f8a941eaa68e89c562129a92314642eec66 |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | COL4A1 COL4A2 TGFBR3 COL5A1 COL5A2 COL24A1 COL6A3 COL16A1 COL27A1 | 6.55e-12 | 189 | 63 | 9 | 44e37f88137bb249933eb615235b2cf2ae7f3925 |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | COL4A1 COL4A2 COL4A3 TGFBR3 COL5A1 COL5A2 COL6A3 ADAMTS17 COL5A3 | 7.20e-12 | 191 | 63 | 9 | 70c067c54084bfb02c29bab085f4defd477194fb |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL4A1 COL4A2 MAGI2 COL5A2 COL6A3 COL16A1 COL6A6 ADAMTS17 EMILIN1 | 7.54e-12 | 192 | 63 | 9 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MAGI2 COL5A1 COL5A2 COL6A3 COL16A1 COL6A6 COL21A1 EMILIN1 PGM5 | 7.54e-12 | 192 | 63 | 9 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | COL4A1 COL5A1 COL5A2 COL24A1 COL6A3 COL11A1 COL16A1 COL6A6 EMILIN1 | 8.28e-12 | 194 | 63 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 COL11A1 COL16A1 COL27A1 EMILIN1 | 8.67e-12 | 195 | 63 | 9 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 COL11A1 COL16A1 COL27A1 EMILIN1 | 8.67e-12 | 195 | 63 | 9 | 095b8e0be385b6390420589124a95fa4ba3682ab |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | MAGI2 TGFBR3 COL5A1 COL5A2 COL6A3 COL16A1 COL6A6 COL21A1 COL5A3 | 9.08e-12 | 196 | 63 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 COL16A1 COL6A6 COL5A3 EMILIN1 | 9.08e-12 | 196 | 63 | 9 | 275e153347caf94edc0c50021bbab49c8696fecb |
| ToppCell | droplet-Bladder-BLADDER-1m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL5A1 COL5A2 COL6A3 COL11A1 COL16A1 TCEAL8 EMILIN1 PGM5 | 9.50e-12 | 197 | 63 | 9 | 1e24150c5146c93914aaaa981bd17589e8ed7cf9 |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL5A2 COL6A3 ITGB1 EMILIN1 | 9.50e-12 | 197 | 63 | 9 | 69fde2d27881f8408216e231c71cfdbd96f28d45 |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A5 COL5A1 COL5A2 COL6A3 COL11A1 COL16A1 TCEAL8 EMILIN1 PGM5 | 9.50e-12 | 197 | 63 | 9 | 036c4c9b3ae80e2dc21c24a84504d3da0541f945 |
| ToppCell | droplet-Bladder-BLADDER|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL5A1 COL5A2 COL6A3 COL11A1 COL16A1 TCEAL8 EMILIN1 PGM5 | 9.50e-12 | 197 | 63 | 9 | 5ae84f796005fa7b75d10b6464770da6cd5c8f53 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL6A3 COL11A1 COL16A1 COL5A3 | 9.94e-12 | 198 | 63 | 9 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL6A3 COL21A1 COL27A1 EMILIN1 | 1.04e-11 | 199 | 63 | 9 | 5b9d355795dd03a22f0961dfd143425c367a4654 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 COL16A1 COL21A1 ITGB1 EMILIN1 | 1.04e-11 | 199 | 63 | 9 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | COL4A1 TGFBR3 COL5A1 COL5A2 COL6A3 COL16A1 COL6A6 COL21A1 ADAMTS17 | 1.04e-11 | 199 | 63 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | COL4A1 COL4A2 TGFBR3 COL5A1 COL5A2 COL6A3 COL16A1 COL6A6 COL21A1 | 1.04e-11 | 199 | 63 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | COL4A1 TGFBR3 COL5A1 COL5A2 COL6A3 COL16A1 COL21A1 MATR3 EMILIN1 | 1.09e-11 | 200 | 63 | 9 | 2cc98abf11f5b58707de45a2282f03d47f00f035 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | COL4A1 COL4A2 TGFBR3 COL5A1 COL5A2 COL6A3 COL5A3 COL22A1 EMILIN1 | 1.09e-11 | 200 | 63 | 9 | ff0b2675c68e9fc1fa16b3276431f199f3642eac |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 COL16A1 COL6A6 COL5A3 EMILIN1 | 1.09e-11 | 200 | 63 | 9 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 FLNC COL6A6 COL21A1 COL5A3 | 1.09e-11 | 200 | 63 | 9 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | COL4A1 COL4A2 TGFBR3 COL5A1 COL5A2 COL6A3 COL5A3 COL22A1 EMILIN1 | 1.09e-11 | 200 | 63 | 9 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | COL4A1 TGFBR3 COL5A1 COL5A2 COL6A3 COL16A1 COL21A1 MATR3 EMILIN1 | 1.09e-11 | 200 | 63 | 9 | 0f7431f670f3a175377cefae3479403a881bb8fb |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL4A1 COL4A2 COL5A1 COL5A2 COL6A3 FLNC COL6A6 COL21A1 COL5A3 | 1.09e-11 | 200 | 63 | 9 | 76f3043cb88071256ff661885fe5a82a54f5b733 |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-10 | 173 | 63 | 8 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-10 | 180 | 63 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-10 | 181 | 63 | 8 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-10 | 181 | 63 | 8 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-10 | 183 | 63 | 8 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-10 | 183 | 63 | 8 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-10 | 183 | 63 | 8 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.15e-10 | 184 | 63 | 8 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-10 | 185 | 63 | 8 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.44e-10 | 187 | 63 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.77e-10 | 190 | 63 | 8 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.89e-10 | 191 | 63 | 8 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-10 | 192 | 63 | 8 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-10 | 192 | 63 | 8 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-10 | 192 | 63 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-10 | 192 | 63 | 8 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-10 | 193 | 63 | 8 | 146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-10 | 193 | 63 | 8 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-10 | 193 | 63 | 8 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-10 | 193 | 63 | 8 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.14e-10 | 193 | 63 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.14e-10 | 193 | 63 | 8 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.14e-10 | 193 | 63 | 8 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-10 | 193 | 63 | 8 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.27e-10 | 194 | 63 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-10 | 194 | 63 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-10 | 194 | 63 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-10 | 194 | 63 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-10 | 195 | 63 | 8 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-10 | 195 | 63 | 8 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-10 | 195 | 63 | 8 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.55e-10 | 196 | 63 | 8 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 3.55e-10 | 196 | 63 | 8 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-10 | 196 | 63 | 8 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.55e-10 | 196 | 63 | 8 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 3.55e-10 | 196 | 63 | 8 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-10 | 196 | 63 | 8 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-10 | 196 | 63 | 8 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.55e-10 | 196 | 63 | 8 | 0b247cf981981ae61aca5de82ef687e8d783c9ef | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-10 | 196 | 63 | 8 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-10 | 197 | 63 | 8 | 6e111ba16fc8adde782b3f7da250248cddf11228 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-10 | 197 | 63 | 8 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.69e-10 | 197 | 63 | 8 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-10 | 197 | 63 | 8 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.69e-10 | 197 | 63 | 8 | 94a7270ea6d4b586f58875c9e4071ce0f683ef7e | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-10 | 197 | 63 | 8 | 4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.69e-10 | 197 | 63 | 8 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-10 | 197 | 63 | 8 | ece0c17eb68f394b20e588c0b0626d3987a4dbbb | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.69e-10 | 197 | 63 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-10 | 198 | 63 | 8 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-10 | 198 | 63 | 8 | 8f202ed4692ea2c139ff05d4805c704ee4be095c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.84e-10 | 198 | 63 | 8 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.84e-10 | 198 | 63 | 8 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-10 | 198 | 63 | 8 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.84e-10 | 198 | 63 | 8 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-10 | 198 | 63 | 8 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-10 | 199 | 63 | 8 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 4.00e-10 | 199 | 63 | 8 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 4.00e-10 | 199 | 63 | 8 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.00e-10 | 199 | 63 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.00e-10 | 199 | 63 | 8 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| Computational | Adhesion molecules. | COL4A1 COL4A5 COL5A1 COL5A2 COL6A3 COL9A2 COL9A3 COL11A1 COL16A1 CDH3 | 3.78e-11 | 141 | 38 | 10 | MODULE_122 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.72e-05 | 50 | 38 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Spinal cord (neuro-development) genes. | 2.29e-04 | 360 | 38 | 7 | MODULE_12 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.12e-04 | 50 | 38 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.12e-04 | 50 | 38 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.12e-04 | 50 | 38 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | ECM and collagens. | 1.10e-03 | 225 | 38 | 5 | MODULE_47 | |
| Computational | Ovary genes. | 1.69e-03 | 368 | 38 | 6 | MODULE_1 | |
| Drug | GK-101 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 2.85e-30 | 36 | 62 | 15 | CID000161853 |
| Drug | Madecassol | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 2.57e-28 | 46 | 62 | 15 | CID000108062 |
| Drug | d-indobufen | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 1.12e-27 | 50 | 62 | 15 | CID000044562 |
| Drug | ridogrel | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 2.23e-27 | 52 | 62 | 15 | CID005362391 |
| Drug | NSC49633 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 3.10e-27 | 53 | 62 | 15 | CID000023340 |
| Drug | strontium ranelate | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 ALPL | 1.34e-26 | 77 | 62 | 16 | CID006918182 |
| Drug | AC1LAKND | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 4.53e-26 | 62 | 62 | 15 | CID000470146 |
| Drug | hydroxylysine | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 MBL2 COL22A1 ALPL | 6.12e-26 | 109 | 62 | 17 | CID000001029 |
| Drug | 4-hydroxyproline | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 ALPL | 2.49e-25 | 91 | 62 | 16 | CID000000825 |
| Drug | BAPN | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 4.38e-25 | 71 | 62 | 15 | CID000001647 |
| Drug | malotilate | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 4.38e-25 | 71 | 62 | 15 | CID000004006 |
| Drug | AC1NMZ1B | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 1.08e-24 | 75 | 62 | 15 | CID005034185 |
| Drug | halofuginone lactate | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 8.38e-24 | 85 | 62 | 15 | CID000062891 |
| Drug | AC1L9732 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 ALPL | 1.18e-23 | 114 | 62 | 16 | CID000439300 |
| Drug | Selara | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 DUOX2 COL22A1 | 5.58e-23 | 125 | 62 | 16 | CID000150310 |
| Drug | DMSe | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL5A3 COL22A1 | 1.39e-22 | 132 | 62 | 16 | CID000020796 |
| Drug | ticlopidine | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 1.84e-22 | 103 | 62 | 15 | CID000005472 |
| Drug | AC1L1C2F | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 5.22e-22 | 110 | 62 | 15 | CID000001711 |
| Drug | PPACK | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 7.99e-22 | 113 | 62 | 15 | CID003036757 |
| Drug | Tranilast sodium | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 1.05e-21 | 115 | 62 | 15 | CID000005527 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 ITGB1 | 4.17e-21 | 162 | 62 | 16 | CID000072363 |
| Drug | pirfenidone | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 1.83e-20 | 138 | 62 | 15 | CID000040632 |
| Drug | DL-penicillamine | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 2.05e-20 | 139 | 62 | 15 | CID000004727 |
| Drug | PCR 4099 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 2.05e-20 | 139 | 62 | 15 | CID000002806 |
| Drug | candesartan cilexetil | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 3.95e-20 | 145 | 62 | 15 | CID000002540 |
| Drug | khellin | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 5.01e-19 | 171 | 62 | 15 | CID000003828 |
| Drug | AC1L1DD6 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 1.01e-18 | 179 | 62 | 15 | CID000002299 |
| Drug | AC1Q6PCP | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 DUOX2 COL22A1 | 1.26e-18 | 230 | 62 | 16 | CID000005267 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 2.31e-18 | 189 | 62 | 15 | CID000001413 |
| Drug | foscarnet | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 2.50e-18 | 190 | 62 | 15 | CID000003414 |
| Drug | losartan | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 DUOX2 DLX4 COL22A1 ITGB1 | 5.83e-18 | 378 | 62 | 18 | CID000003961 |
| Drug | hyaluronan | COL4A1 COL4A3 COL4A5 COL4A6 TGFBR3 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 1.08e-17 | 263 | 62 | 16 | CID000024759 |
| Drug | silibinin | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 ALPL | 3.89e-17 | 285 | 62 | 16 | CID000005213 |
| Drug | prostacyclin sodium salt | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 1.57e-16 | 250 | 62 | 15 | CID000000159 |
| Drug | colchine | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 MEFV ALPL | 1.80e-16 | 383 | 62 | 17 | CID000002833 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 ITGB1 | 1.80e-16 | 314 | 62 | 16 | CID000447989 |
| Drug | chondroitin sulfate | COL4A1 COL4A3 COL4A5 COL4A6 TGFBR3 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 ITGB1 | 6.30e-16 | 413 | 62 | 17 | CID000024766 |
| Drug | AC1L1KMJ | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 ITGB1 MARCO | 6.53e-15 | 476 | 62 | 17 | CID000030956 |
| Drug | AC1L18QD | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 7.66e-15 | 325 | 62 | 15 | CID000000213 |
| Drug | Y-27632 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 DUOX2 COL22A1 | 4.02e-14 | 444 | 62 | 16 | CID000005711 |
| Drug | L-3,4-dehydroproline | COL5A1 COL6A3 COL8A2 COL9A3 COL11A1 COL16A1 COL21A1 COL22A1 ALPL | 3.81e-13 | 73 | 62 | 9 | CID000094284 |
| Drug | LMWH | COL4A1 COL4A3 COL4A5 COL4A6 TGFBR3 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 KCNA6 COL21A1 COL27A1 COL22A1 | 1.39e-12 | 663 | 62 | 17 | CID000000772 |
| Drug | aspirin | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 COL21A1 COL27A1 COL22A1 | 2.10e-11 | 563 | 62 | 15 | CID000002244 |
| Drug | LS-63783 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL16A1 KCNA6 COL21A1 COL27A1 COL22A1 ALPL | 2.91e-11 | 804 | 62 | 17 | CID000000231 |
| Drug | isodesmosine | 3.33e-10 | 33 | 62 | 6 | CID000013811 | |
| Drug | dermatan sulfate | COL4A3 COL4A5 TGFBR3 COL5A1 COL6A3 COL9A2 COL9A3 COL11A1 COL21A1 COL27A1 | 4.01e-10 | 220 | 62 | 10 | CID000032756 |
| Drug | NC-4 | 2.07e-09 | 44 | 62 | 6 | CID006420119 | |
| Drug | desmosine | 6.61e-09 | 53 | 62 | 6 | CID000025435 | |
| Drug | pyridinoline | 9.58e-09 | 99 | 62 | 7 | CID000105068 | |
| Drug | pyrachlostrobin | COL4A1 COL4A5 COL4A6 COL5A1 COL5A2 FLNC COL8A2 COL11A1 COL16A1 COL5A3 COL22A1 ITGB1 PBXIP1 PGM5 | 2.81e-08 | 811 | 62 | 14 | ctd:C513428 |
| Drug | 351A | 2.34e-07 | 20 | 62 | 4 | CID000122144 | |
| Drug | 2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid | 2.99e-07 | 52 | 62 | 5 | ctd:C573693 | |
| Drug | BPAT-143 | 3.82e-07 | 6 | 62 | 3 | CID000146249 | |
| Drug | 1h00 | 4.36e-07 | 56 | 62 | 5 | CID000445950 | |
| Drug | diphenylamine-2-carboxylate | 5.61e-06 | 164 | 62 | 6 | CID000004386 | |
| Drug | PD123177 | 5.68e-06 | 43 | 62 | 4 | CID000114899 | |
| Drug | 1zd2 | 6.83e-06 | 45 | 62 | 4 | CID004149241 | |
| Drug | fluoride | 1.04e-05 | 278 | 62 | 7 | CID000014917 | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.30e-05 | 190 | 62 | 6 | 3629_UP | |
| Drug | Roxarsone [121-19-7]; Up 200; 15.2uM; PC3; HT_HG-U133A | 1.60e-05 | 197 | 62 | 6 | 5051_UP | |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 1.64e-05 | 198 | 62 | 6 | 4147_UP | |
| Drug | sodium chloride | COL4A3 COL4A5 COL5A1 COL6A3 COL8A2 COL9A2 COL9A3 COL11A1 COL21A1 MBL2 PGM5 | 1.93e-05 | 865 | 62 | 11 | CID000000206 |
| Drug | CP-331 | 2.18e-05 | 3 | 62 | 2 | CID000130967 | |
| Drug | AC1Q641C | 2.47e-05 | 62 | 62 | 4 | CID000005005 | |
| Drug | 2,3-pentanedione | 2.70e-05 | 129 | 62 | 5 | ctd:C013186 | |
| Drug | NSC-333492 | 4.36e-05 | 4 | 62 | 2 | CID000333256 | |
| Drug | Brn 2557402 | 4.36e-05 | 4 | 62 | 2 | CID000042742 | |
| Drug | HepIII | 5.37e-05 | 27 | 62 | 3 | CID003036270 | |
| Drug | 17-isoprogesterone | COL4A3 COL4A5 COL5A1 COL8A2 COL11A1 COL16A1 GAR1 COL21A1 COL27A1 DLX4 PSPC1 ALPL | 6.37e-05 | 1170 | 62 | 12 | CID000004920 |
| Drug | dimethylmalonimidate | 7.26e-05 | 5 | 62 | 2 | CID000189133 | |
| Drug | Cyclo-rgdphg | 7.26e-05 | 5 | 62 | 2 | CID006449872 | |
| Drug | Coal Ash | 7.32e-05 | 159 | 62 | 5 | ctd:D060729 | |
| Drug | 4-fluoranylproline | 1.09e-04 | 6 | 62 | 2 | CID000450594 | |
| Drug | In2-7 | 1.09e-04 | 6 | 62 | 2 | CID002816385 | |
| Drug | beta Carotene | 1.15e-04 | 175 | 62 | 5 | ctd:D019207 | |
| Drug | AC1L9HPX | 1.16e-04 | 92 | 62 | 4 | CID000445279 | |
| Drug | angiotensin | 1.18e-04 | 282 | 62 | 6 | CID003083715 | |
| Drug | Sirius red | 1.18e-04 | 35 | 62 | 3 | CID005486818 | |
| Drug | AGN-1133 | 1.21e-04 | 93 | 62 | 4 | CID000015178 | |
| Drug | thapsigargin; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.28e-04 | 179 | 62 | 5 | 7103_DN | |
| Drug | AC1L1HWN | 1.52e-04 | 7 | 62 | 2 | CID000004323 | |
| Drug | AC1MRIIV | 1.64e-04 | 39 | 62 | 3 | CID003518584 | |
| Drug | estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.77e-04 | 192 | 62 | 5 | 5955_UP | |
| Drug | Clozapine [5786-21-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.82e-04 | 193 | 62 | 5 | 4670_UP | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.86e-04 | 194 | 62 | 5 | 7137_DN | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.86e-04 | 194 | 62 | 5 | 4082_UP | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.86e-04 | 194 | 62 | 5 | 3610_UP | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; HL60; HT_HG-U133A | 1.91e-04 | 195 | 62 | 5 | 3054_UP | |
| Drug | Daunorubicin hydrochloride [23541-50-6]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.91e-04 | 195 | 62 | 5 | 4983_UP | |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.95e-04 | 196 | 62 | 5 | 4499_UP | |
| Drug | Cyproterone acetate [427-51-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.95e-04 | 196 | 62 | 5 | 3545_UP | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.95e-04 | 196 | 62 | 5 | 7225_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; PC3; HT_HG-U133A | 1.95e-04 | 196 | 62 | 5 | 4508_UP | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 3617_UP | |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 3192_UP | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 6714_UP | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 4152_UP | |
| Drug | rotenone; Up 200; 1uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 5915_UP | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 3881_UP | |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 7248_DN | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.27e-11 | 53 | 59 | 7 | C4707243 | |
| Disease | collagen disease (implicated_via_orthology) | 7.05e-09 | 12 | 59 | 4 | DOID:854 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 4.31e-08 | 48 | 59 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | Stickler syndrome, type 1 | 7.57e-08 | 5 | 59 | 3 | C2020284 | |
| Disease | Intervertebral disc disorder | 1.51e-07 | 6 | 59 | 3 | C0158252 | |
| Disease | Early Pregnancy Loss | 2.68e-06 | 109 | 59 | 5 | C3830362 | |
| Disease | Miscarriage | 2.68e-06 | 109 | 59 | 5 | C4552766 | |
| Disease | Spontaneous abortion | 2.68e-06 | 109 | 59 | 5 | C0000786 | |
| Disease | Abortion, Tubal | 2.68e-06 | 109 | 59 | 5 | C0000822 | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 3.93e-06 | 2 | 59 | 2 | C1839884 | |
| Disease | Ehlers-Danlos syndrome type 1 | 3.93e-06 | 2 | 59 | 2 | C0268335 | |
| Disease | Ehlers-Danlos syndrome type 2 | 3.93e-06 | 2 | 59 | 2 | C0268336 | |
| Disease | Developmental Porencephaly | 3.93e-06 | 2 | 59 | 2 | C4082301 | |
| Disease | Post-traumatic Porencephaly | 3.93e-06 | 2 | 59 | 2 | C3698507 | |
| Disease | Congenital porencephaly | 3.93e-06 | 2 | 59 | 2 | C0302892 | |
| Disease | Porencephaly | 3.93e-06 | 2 | 59 | 2 | C4082173 | |
| Disease | PORENCEPHALY, FAMILIAL | 3.93e-06 | 2 | 59 | 2 | C1867983 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 3.93e-06 | 2 | 59 | 2 | C3281105 | |
| Disease | Ehlers-Danlos syndrome classic type | 3.93e-06 | 2 | 59 | 2 | C4225429 | |
| Disease | Ehlers-Danlos syndrome, classic type | 3.93e-06 | 2 | 59 | 2 | cv:C4225429 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 3.93e-06 | 2 | 59 | 2 | C4551998 | |
| Disease | Leiomyoma, Epithelioid | 3.93e-06 | 2 | 59 | 2 | C0086533 | |
| Disease | intraocular pressure measurement | 7.61e-06 | 509 | 59 | 8 | EFO_0004695 | |
| Disease | Multiple Epiphyseal Dysplasia | 8.45e-06 | 20 | 59 | 3 | C0026760 | |
| Disease | Stickler syndrome (disorder) | 1.18e-05 | 3 | 59 | 2 | C0265253 | |
| Disease | Alport syndrome (is_implicated_in) | 1.18e-05 | 3 | 59 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 1.18e-05 | 3 | 59 | 2 | C4552122 | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 1.18e-05 | 3 | 59 | 2 | C0220679 | |
| Disease | Ehlers-Danlos syndrome classic type 1 (implicated_via_orthology) | 1.18e-05 | 3 | 59 | 2 | DOID:14720 (implicated_via_orthology) | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 1.18e-05 | 3 | 59 | 2 | cv:C3281105 | |
| Disease | Alport syndrome | 1.18e-05 | 3 | 59 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 1.18e-05 | 3 | 59 | 2 | cv:CN076135 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.18e-05 | 3 | 59 | 2 | 614519 | |
| Disease | Hematuria, Benign Familial | 2.35e-05 | 4 | 59 | 2 | C0241908 | |
| Disease | Stickler syndrome (is_implicated_in) | 2.35e-05 | 4 | 59 | 2 | DOID:0080046 (is_implicated_in) | |
| Disease | congenital hypothyroidism (is_implicated_in) | 2.35e-05 | 4 | 59 | 2 | DOID:0050328 (is_implicated_in) | |
| Disease | Alport Syndrome | 2.35e-05 | 4 | 59 | 2 | C1567741 | |
| Disease | corneal resistance factor | 3.20e-05 | 451 | 59 | 7 | EFO_0010067 | |
| Disease | Stickler syndrome | 3.92e-05 | 5 | 59 | 2 | cv:C0265253 | |
| Disease | Multiple Epiphyseal Dysplasia, Dominant | 3.92e-05 | 5 | 59 | 2 | cv:CN043640 | |
| Disease | INTERVERTEBRAL DISC DISEASE | 3.92e-05 | 5 | 59 | 2 | 603932 | |
| Disease | Lumbar disc disease | 3.92e-05 | 5 | 59 | 2 | C0221775 | |
| Disease | Intervertebral disc disorder | 3.92e-05 | 5 | 59 | 2 | cv:C0158252 | |
| Disease | Alport Syndrome, X-Linked | 3.92e-05 | 5 | 59 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 3.92e-05 | 5 | 59 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 3.92e-05 | 5 | 59 | 2 | C1567744 | |
| Disease | Congenital hypothyroidism | 5.87e-05 | 6 | 59 | 2 | cv:C0010308 | |
| Disease | cervical cancer | 7.12e-05 | 40 | 59 | 3 | MONDO_0002974 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 8.20e-05 | 7 | 59 | 2 | C1846545 | |
| Disease | Bleeding tendency | 8.20e-05 | 7 | 59 | 2 | C1458140 | |
| Disease | Ehlers-Danlos syndrome | 1.09e-04 | 8 | 59 | 2 | cv:C0013720 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 1.40e-04 | 9 | 59 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Hematuria | 1.40e-04 | 9 | 59 | 2 | C0018965 | |
| Disease | Small cell carcinoma of lung | 1.75e-04 | 54 | 59 | 3 | C0149925 | |
| Disease | Hereditary hearing loss and deafness | 2.12e-04 | 146 | 59 | 4 | cv:C0236038 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee | 2.64e-04 | 62 | 59 | 3 | EFO_0004616, EFO_1000786 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.67e-04 | 447 | 59 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | non-lobar intracerebral hemorrhage | 2.77e-04 | 63 | 59 | 3 | EFO_0010178 | |
| Disease | Congenital Hypothyroidism | 3.02e-04 | 13 | 59 | 2 | C0010308 | |
| Disease | Connective Tissue Diseases | 3.02e-04 | 13 | 59 | 2 | C0009782 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 3.52e-04 | 14 | 59 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | central corneal thickness | 3.84e-04 | 309 | 59 | 5 | EFO_0005213 | |
| Disease | Blood Coagulation Disorders | 4.63e-04 | 16 | 59 | 2 | C0005779 | |
| Disease | Disproportionate short stature | 5.00e-04 | 77 | 59 | 3 | C0878659 | |
| Disease | Cleft Palate | 5.80e-04 | 81 | 59 | 3 | C0008925 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 6.58e-04 | 19 | 59 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Disorder of eye | 8.65e-04 | 212 | 59 | 4 | C0015397 | |
| Disease | Renal glomerular disease | 9.68e-04 | 23 | 59 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 9.68e-04 | 23 | 59 | 2 | C4521256 | |
| Disease | nicotine withdrawal measurement | 1.34e-03 | 27 | 59 | 2 | EFO_0009362 | |
| Disease | Nephrotic Syndrome | 1.34e-03 | 27 | 59 | 2 | C0027726 | |
| Disease | caudate volume change measurement, age at assessment | 1.34e-03 | 27 | 59 | 2 | EFO_0008007, EFO_0021491 | |
| Disease | corneal topography | 1.37e-03 | 109 | 59 | 3 | EFO_0004345 | |
| Disease | Cerebral Hemorrhage | 1.44e-03 | 28 | 59 | 2 | C2937358 | |
| Disease | thoracic aortic aneurysm | 1.65e-03 | 30 | 59 | 2 | EFO_0004282 | |
| Disease | spontaneous coronary artery dissection | 1.76e-03 | 31 | 59 | 2 | EFO_0010820 | |
| Disease | urate measurement | 2.00e-03 | 895 | 59 | 7 | EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQGKKGTLGFPGLNG | 316 | Q14031 | |
| PGLNGFQGIEGQKGD | 326 | Q14031 | |
| FQGIEGQKGDIGLPG | 331 | Q14031 | |
| QGFRGVIGEPGKDGV | 566 | Q14031 | |
| KGRDGLIGNIGFPGN | 1096 | Q14031 | |
| LIGNIGFPGNKGEDG | 1101 | Q14031 | |
| GQKGDRGFPGLQGPA | 1226 | Q14031 | |
| DGQNGVPGLDGQKGE | 306 | Q14050 | |
| VPGLDGQKGEAGRNG | 311 | Q14050 | |
| GGGPVLGRNKNELEG | 576 | Q02641 | |
| GFAGNPGEKGNRGVP | 961 | Q01955 | |
| GERGLKGQKGDAGNP | 676 | Q07092 | |
| QQGQTGLRGTPGEKG | 851 | Q07092 | |
| GLQGFPGLQGRKGDK | 76 | P08572 | |
| GQQGNRGLGFYGVKG | 226 | P08572 | |
| LKQNSGGQEGDFPGR | 176 | Q92988 | |
| GGARYLGNNQVPGGK | 316 | Q8TE56 | |
| GLSFQGPKGDKGDQG | 221 | P02462 | |
| GLIGRQGPQGEKGEA | 311 | P02462 | |
| LPGLQGIKGDQGDQG | 1321 | P02462 | |
| GGLNQLGGAFVNGRP | 11 | Q06710 | |
| GDGKLGGIVLPNDGQ | 286 | P05556 | |
| GGPGGEFGVKFNVAN | 126 | Q15124 | |
| GCQNPFRQGGGRKGL | 1866 | Q9NU22 | |
| GPRGNLGAGNGNLQG | 371 | P43243 | |
| GRNPEGQLGFELKGG | 21 | Q86UL8 | |
| GQLGFELKGGAENGQ | 26 | Q86UL8 | |
| APGNLLVKEGFGEGG | 476 | Q8N5S9 | |
| GGGGNGIRDIFKQNI | 946 | Q9NRD8 | |
| EQGEKGDRGLPGTQG | 1466 | P12107 | |
| FGPGLEGGLVNKANR | 1356 | Q14315 | |
| KIGGRDQGRPFQGQV | 1296 | Q9P2S2 | |
| GGRQENGPGGKGRDQ | 141 | P57055 | |
| NGPGGKGRDQGINQG | 146 | P57055 | |
| KGEKGEPGQGLRGLQ | 56 | P11226 | |
| EGGGVHQQAGPGQGR | 111 | Q9HBQ8 | |
| GRLQGLAGGAPGQKE | 211 | O15553 | |
| GQQTGGRGVLPQGKE | 661 | Q86Y26 | |
| GNGPGYKVVGGEREN | 416 | P05186 | |
| KRPVGGFLLDGFQGN | 211 | Q9H974 | |
| LPQFRVDGRGGNNGG | 196 | P17658 | |
| GVGGQDGLGAPKDQQ | 71 | Q9P2G3 | |
| APGIGQQGIKGERGQ | 356 | Q2UY09 | |
| QQGIKGERGQEGRPG | 361 | Q2UY09 | |
| DRGLKGDNGVGQPGL | 201 | P25067 | |
| AGALGQKGDLGLPGQ | 441 | P25067 | |
| NFQGPKGEKGEQGLQ | 221 | P29400 | |
| GSLGFPGQKGEKGQA | 506 | P29400 | |
| VGEKGIQGVAGNPGQ | 631 | P29400 | |
| SGVPGLKGDDGLQGQ | 916 | P29400 | |
| TQGFQGCPGQRGVKG | 2081 | P12111 | |
| GQPGFEGEQGTRGAQ | 2216 | P12111 | |
| QKGDQGERGPVGQPG | 386 | Q14055 | |
| QKGENGRQGIPGQQG | 711 | Q96P44 | |
| NFGRGRKGQKGEPGL | 106 | P05997 | |
| GPRGQQGLFGQKGDE | 1201 | P20908 | |
| QGLFGQKGDEGPRGF | 1206 | P20908 | |
| LPGRDGQAGQQGEQG | 1446 | Q8IZC6 | |
| FPGVRGEKGDQGEKG | 811 | Q8NFW1 | |
| LQGQQGRKGESGVPG | 356 | Q9UEW3 | |
| GLGGEGPGESEKVQQ | 166 | Q9Y6C2 | |
| GGAEQEPGQALGKVF | 41 | P22223 | |
| KALGVQGGQAGVPEG | 36 | P25940 | |
| EKGQRGDFGHVGQPG | 561 | P25940 | |
| EAGEKGDQGLPGVQG | 1416 | P25940 | |
| GPKGNRGLNGQEGEV | 1446 | A6NMZ7 | |
| EQGDNGLPGRKGEKG | 1471 | A6NMZ7 | |
| NQGRLGSQGNKGEPG | 1616 | A6NMZ7 | |
| PDFGFGGQKRQLEDG | 101 | Q92945 | |
| GGFNKGQDQGPPERV | 56 | Q9NY12 | |
| EGNGKEGGGQGLVPV | 386 | Q14D33 | |
| GQEEDGPLKGKGQGA | 171 | P49848 | |
| RGGPNQPGQGFKEDT | 51 | Q8IYN2 | |
| QDGPQQQTGGRGGGR | 326 | Q8NCA5 | |
| GFQLGQPDEVRGGGG | 61 | O94818 | |
| QPDEVRGGGGGAKQV | 66 | O94818 | |
| NKINGEPRGGGAGGN | 1576 | Q8IWZ3 | |
| PDGLLGEQGIQGAKG | 931 | Q17RW2 | |
| GEPGDQGEQGLKGER | 1246 | Q17RW2 | |
| QPGIQGKRGHRGAQG | 1361 | Q17RW2 | |
| IFDTQKGQGPGGDGF | 151 | O15417 | |
| KGLQEGFGEGQGLQA | 331 | P0CB47 | |
| GEGQKGGEQPKLVRG | 1616 | Q8IVF5 | |
| GGRGPQGDKAIREQG | 356 | Q96AQ6 | |
| GRGSQGGNFEGPNKR | 506 | Q8WXF1 | |
| QLNGKPVGHEGGLRG | 146 | Q5JSZ5 | |
| EALQNGQLGGGEGVP | 161 | Q9H9P5 | |
| EFGQSNRKGEFPGGL | 1261 | Q70CQ2 | |
| GYVPGRGLGKNAQGI | 161 | Q9UBB9 | |
| LQNPPIRGGEGQNGG | 386 | Q03167 |